Characterization	O
of	O
a	O
mutant	B-cell_line
cell	I-cell_line
line	I-cell_line
that	O
does	O
not	O
activate	O
NF-kappaB	B-protein
in	O
response	O
to	O
multiple	O
stimuli	O
.	O

Numerous	O
genes	O
required	O
during	O
the	O
immune	O
or	O
inflammation	O
response	O
as	O
well	O
as	O
the	O
adhesion	O
process	O
are	O
regulated	O
by	O
nuclear	B-protein
factor	I-protein
kappaB	I-protein
(	O
NF-kappaB	B-protein
)	O
.	O

Associated	O
with	O
its	O
inhibitor	O
,	O
I	B-protein
kappaB	I-protein
,	O
NF-kappaB	B-protein
resides	O
as	O
an	O
inactive	O
form	O
in	O
the	O
cytoplasm	O
.	O

Upon	O
stimulation	O
by	O
various	O
agents	O
,	O
I	B-protein
kappaB	I-protein
is	O
proteolyzed	O
and	O
NF-kappaB	B-protein
translocates	O
to	O
the	O
nucleus	O
,	O
where	O
it	O
activates	O
its	O
target	O
genes	O
.	O

The	O
transduction	O
pathways	O
that	O
lead	O
to	O
I	B-protein
kappaB	I-protein
inactivation	O
remain	O
poorly	O
understood	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
characterized	O
a	O
cellular	O
mutant	O
,	O
the	O
70/Z3-derived	B-cell_line
1.3E2	I-cell_line
murine	I-cell_line
pre-B	I-cell_line
cell	I-cell_line
line	I-cell_line
,	O
that	O
does	O
not	O
activate	O
NF-kappaB	B-protein
in	O
response	O
to	O
several	O
stimuli	O
.	O

We	O
demonstrate	O
that	O
upon	O
stimulation	O
by	O
lipopolysaccharide	O
,	O
Taxol	O
,	O
phorbol	O
myristate	O
acetate	O
,	O
interleukin-1	B-protein
,	O
or	O
double-stranded	B-RNA
RNA	I-RNA
,	O
I	B-protein
kappaB	I-protein
alpha	I-protein
is	O
not	O
degraded	O
,	O
as	O
a	O
result	O
of	O
an	O
absence	O
of	O
induced	O
phosphorylation	O
on	O
serines	O
32	O
and	O
36	O
.	O

Neither	O
a	O
mutation	O
in	O
I	B-protein
kappaB	I-protein
alpha	I-protein
nor	O
a	O
mutation	O
in	O
p50	B-protein
or	O
relA	B-protein
,	O
the	O
two	O
major	O
subunits	O
of	O
NF-kappaB	B-protein
in	O
this	O
cell	O
line	O
,	O
accounts	O
for	O
this	O
phosphorylation	O
defect	O
.	O

As	O
well	O
as	O
culminating	O
in	O
the	O
inducible	O
phosphorylation	O
of	O
I	B-protein
kappaB	I-protein
alpha	O
on	O
serines	O
32	O
and	O
36	O
,	O
all	O
the	O
stimuli	O
that	O
are	O
inactive	O
on	O
1.3E2	B-cell_line
cells	I-cell_line
exhibit	O
a	O
sensitivity	O
to	O
the	O
antioxidant	O
pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
)	O
.	O

In	O
contrast	O
,	O
stimuli	O
such	O
as	O
hyperosmotic	O
shock	O
or	O
phosphatase	O
inhibitors	O
,	O
which	O
use	O
PDTC-insensitive	O
pathways	O
,	O
induce	O
I	B-protein
kappaB	I-protein
alpha	O
degradation	O
in	O
1.3E2	B-cell_line
.	O

Analysis	O
of	O
the	O
redox	O
status	O
of	O
1.3E2	B-cell_line
does	O
not	O
reveal	O
any	O
difference	O
from	O
wild-type	B-cell_line
70Z/3	I-cell_line
.	O

We	O
also	O
report	O
that	O
the	O
human	B-protein
T-cell	I-protein
leukemia	I-protein
virus	I-protein
type	I-protein
1	I-protein
(	I-protein
HTLV-1	I-protein
)	I-protein
-derived	I-protein
Tax	I-protein
trans-activator	I-protein
induces	O
NF-kappaB	B-protein
activity	O
in	O
1.3E2	B-cell_line
,	O
suggesting	O
that	O
this	O
viral	O
protein	O
does	O
not	O
operate	O
via	O
the	O
defective	O
pathway	O
.	O

Finally	O
,	O
we	O
show	O
that	O
two	O
other	O
I	B-protein
kappaB	I-protein
molecules	I-protein
,	O
I	B-protein
kappaB	I-protein
beta	I-protein
and	O
the	O
recently	O
identified	O
I	B-protein
kappaB	I-protein
epsilon	I-protein
,	O
are	O
not	O
degraded	O
in	O
the	O
1.3E2	B-cell_line
cell	O
line	O
following	O
stimulation	O
.	O

Our	O
results	O
demonstrate	O
that	O
1.3E2	B-cell_line
is	O
a	O
cellular	B-protein
transduction	I-protein
mutant	I-protein
exhibiting	O
a	O
defect	O
in	O
a	O
step	O
that	O
is	O
required	O
by	O
several	O
different	O
stimuli	O
to	O
activate	O
NF-kappaB	B-protein
.	O

In	O
addition	O
,	O
this	O
analysis	O
suggests	O
a	O
common	O
step	O
in	O
the	O
signaling	O
pathways	O
that	O
trigger	O
I	B-protein
kappaB	I-protein
alpha	I-protein
,	O
I	B-protein
kappaB	I-protein
beta	I-protein
,	O
and	O
I	B-protein
kappaB	I-protein
epsilon	I-protein
degradation	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLoGY	NULL
,	NULL
Mar	NULL
.	NULL

1997	NULL
,	NULL
p.	NULL
1441-1449	NULL
0270-7306/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

17	NULL
,	NULL
No	NULL
.	NULL

3	NULL
Characterization	NULL
of	NULL
a	NULL
Mutant	NULL
Cell	NULL
Line	NULL
That	NULL
Does	NULL
Not	NULL
Activate	NULL
NF-kB	NULL
in	NULL
Response	NULL
to	NULL
Multiple	NULL
Stimuli	NULL
GILLES	NULL
COURTOIS	NULL
,	NULL
'	NULL
SIMON	NULL
T.	NULL
WHITESIDE	NULL
,	NULL
'	NULL
CAROL	NULL
H.	NULL
SIBLEY	NULL
,	NULL
``	NULL
anp	NULL
ALAIN	NULL
ISRAEL	NULL
'	NULL
!	NULL

*	NULL
Unité	NULL
de	NULL
Biologie	NULL
Moléculaire	NULL
de	NULL
l'Expression	NULL
Génique	NULL
,	NULL
UMR	NULL
321	NULL
CNRS	NULL
,	NULL
Institut	NULL
Pasteur	NULL
,	NULL
75724	NULL
Paris	NULL
Cedex	NULL
15	NULL
,	NULL
France	NULL
,	NULL
``	NULL
and	NULL
Department	NULL
of	NULL
Genetics	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
Washington	NULL
98195	NULL
%	NULL
Received	NULL
5	NULL
September	NULL
1996/Returned	NULL
for	NULL
modification	NULL
28	NULL
October	NULL
1996/Accepted	NULL
10	NULL
December	NULL
1996	NULL
Numerous	NULL
genes	NULL
required	NULL
during	NULL
the	NULL
immune	NULL
or	NULL
inflammation	NULL
response	NULL
as	NULL
well	NULL
as	NULL
the	NULL
adhesion	NULL
process	NULL
are	NULL
regulated	NULL
by	NULL
nuclear	NULL
factor	NULL
xB	NULL
(	NULL
NF-KB	NULL
)	NULL
.	NULL

Associated	NULL
with	NULL
its	NULL
inhibitor	NULL
,	NULL
IB	NULL
,	NULL
NF-KB	NULL
resides	NULL
as	NULL
an	NULL
inactive	NULL
form	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

Upon	NULL
stimulation	NULL
by	NULL
various	NULL
agents	NULL
,	NULL
IB	NULL
is	NULL
proteolyzed	NULL
and	NULL
NF-KB	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
activates	NULL
its	NULL
target	NULL
genes	NULL
.	NULL

The	NULL
transduction	NULL
pathways	NULL
that	NULL
lead	NULL
to	NULL
IB	NULL
inactivation	NULL
remain	NULL
poorly	NULL
understood	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
characterized	NULL
a	NULL
cellular	NULL
mutant	NULL
,	NULL
the	NULL
70/Z3-derived	NULL
1.3E2	NULL
murine	NULL
pre-B	NULL
cell	NULL
line	NULL
,	NULL
that	NULL
does	NULL
not	NULL
activate	NULL
NF-B	NULL
in	NULL
response	NULL
to	NULL
several	NULL
stimuli	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
upon	NULL
stimulation	NULL
by	NULL
lipopolysaccharide	NULL
,	NULL
Taxol	NULL
,	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
,	NULL
interleukin-1	NULL
,	NULL
or	NULL
double-stranded	NULL
RNA	NULL
,	NULL
IxBa	NULL
is	NULL
not	NULL
degraded	NULL
,	NULL
as	NULL
a	NULL
result	NULL
of	NULL
an	NULL
absence	NULL
of	NULL
induced	NULL
phosphorylation	NULL
on	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
.	NULL

Neither	NULL
a	NULL
mutation	NULL
in	NULL
IxBa	NULL
nor	NULL
a	NULL
mutation	NULL
in	NULL
p50	NULL
or	NULL
relA	NULL
,	NULL
the	NULL
two	NULL
major	NULL
subunits	NULL
of	NULL
NF-KB	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
,	NULL
accounts	NULL
for	NULL
this	NULL
phosphorylation	NULL
defect	NULL
.	NULL

As	NULL
well	NULL
as	NULL
culminating	NULL
in	NULL
the	NULL
inducible	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
on	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
,	NULL
all	NULL
the	NULL
stimuli	NULL
that	NULL
are	NULL
inactive	NULL
on	NULL
1.3E2	NULL
cells	NULL
exhibit	NULL
a	NULL
sensitivity	NULL
to	NULL
the	NULL
antioxidant	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
stimuli	NULL
such	NULL
as	NULL
hyperosmotic	NULL
shock	NULL
or	NULL
phosphatase	NULL
inhibitors	NULL
,	NULL
which	NULL
use	NULL
PDTC-insensitive	NULL
pathways	NULL
,	NULL
induce	NULL
IxBa	NULL
degradation	NULL
in	NULL
1.3E2	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
redox	NULL
status	NULL
of	NULL
1.3E2	NULL
does	NULL
not	NULL
reveal	NULL
any	NULL
difference	NULL
from	NULL
wild-type	NULL
702/3	NULL
.	NULL

We	NULL
also	NULL
report	NULL
that	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
-derived	NULL
Tax	NULL
trans-activator	NULL
induces	NULL
NF-KB	NULL
activity	NULL
in	NULL
1.3E2	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
viral	NULL
protein	NULL
does	NULL
not	NULL
operate	NULL
via	NULL
the	NULL
defective	NULL
pathway	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
show	NULL
that	NULL
two	NULL
other	NULL
IB	NULL
molecules	NULL
,	NULL
IBB	NULL
and	NULL
the	NULL
recently	NULL
identified	NULL
IxBsg	NULL
,	NULL
are	NULL
not	NULL
degraded	NULL
in	NULL
the	NULL
1.3E2	NULL
cell	NULL
line	NULL
following	NULL
stimulation	NULL
.	NULL

Our	NULL
results	NULL
demonstrate	NULL
that	NULL
1.3E2	NULL
is	NULL
a	NULL
cellular	NULL
transduction	NULL
mutant	NULL
exhibiting	NULL
a	NULL
defect	NULL
in	NULL
a	NULL
step	NULL
that	NULL
is	NULL
required	NULL
by	NULL
several	NULL
different	NULL
stimuli	NULL
to	NULL
activate	NULL
NF-KB	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
this	NULL
analysis	NULL
suggests	NULL
a	NULL
common	NULL
step	NULL
in	NULL
the	NULL
signaling	NULL
pathways	NULL
that	NULL
trigger	NULL
IxBa	NULL
,	NULL
IBB	NULL
,	NULL
and	NULL
IxBzg	NULL
degradation	NULL
.	NULL

The	NULL
NF-xB/rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
numerous	NULL
genes	NULL
that	NULL
participate	NULL
in	NULL
the	NULL
immune	NULL
or	NULL
inflammatory	NULL
response	NULL
and	NULL
in	NULL
the	NULL
adhesion	NULL
processes	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
references	NULL
3	NULL
,	NULL
18	NULL
,	NULL
51	NULL
,	NULL
and	NULL
59	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
these	NULL
factors	NULL
are	NULL
required	NULL
for	NULL
the	NULL
transcription	NULL
of	NULL
several	NULL
viruses	NULL
,	NULL
among	NULL
them	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
molecules	NULL
are	NULL
homo-	NULL
or	NULL
heterodimeric	NULL
combinations	NULL
of	NULL
rel-related	NULL
proteins	NULL
.	NULL

Members	NULL
of	NULL
this	NULL
family	NULL
are	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
relA	NULL
,	NULL
relB	NULL
,	NULL
and	NULL
c-rel	NULL
(	NULL
8	NULL
,	NULL
9	NULL
,	NULL
19	NULL
,	NULL
24	NULL
,	NULL
33	NULL
,	NULL
37	NULL
,	NULL
42-44	NULL
,	NULL
46	NULL
,	NULL
62	NULL
)	NULL
.	NULL

They	NULL
all	NULL
share	NULL
a	NULL
conserved	NULL
domain	NULL
,	NULL
the	NULL
rel	NULL
homology	NULL
domain	NULL
,	NULL
that	NULL
participates	NULL
in	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
.	NULL

In	NULL
most	NULL
cell	NULL
types	NULL
,	NULL
NF-B	NULL
resides	NULL
in	NULL
the	NULL
cytoplasm	NULL
in	NULL
a	NULL
latent	NULL
form	NULL
that	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
inhibitor	NULL
IxB	NULL
.	NULL

IxB	NULL
retains	NULL
NF-kB	NULL
in	NULL
the	NULL
cytoplasm	NULL
by	NULL
masking	NULL
its	NULL
nuclear	NULL
localization	NULL
signal	NULL
.	NULL

In	NULL
response	NULL
to	NULL
multiple	NULL
stimuli	NULL
,	NULL
including	NULL
phorbol	NULL
es-ters	NULL
,	NULL
cytokines	NULL
,	NULL
bacterial	NULL
lipopolysaccharides	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
and	NULL
viral	NULL
products	NULL
,	NULL
the	NULL
inhibitor	NULL
is	NULL
inactivated	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
activates	NULL
its	NULL
target	NULL
genes	NULL
.	NULL

Three	NULL
major	NULL
IxB	NULL
molecules	NULL
,	NULL
IxBa	NULL
,	NULL
IxBB	NULL
and	NULL
IxBg	NULL
,	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
21	NULL
,	NULL
55	NULL
,	NULL
61	NULL
)	NULL
.	NULL

Important	NULL
progress	NULL
has	NULL
been	NULL
made	NULL
concerning	NULL
the	NULL
mode	NULL
of	NULL
inactivation	NULL
of	NULL
IxBa	NULL
«	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
induced	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
on	NULL
Ser	NULL
32	NULL
and	NULL
36	NULL
targets	NULL
the	NULL
molecule	NULL
for	NULL
ubiquitination	NULL
and	NULL
subsequent	NULL
degradation	NULL
by	NULL
the	NULL
proteasome	NULL
complex	NULL
(	NULL
4	NULL
,	NULL
7	NULL
,	NULL
10	NULL
,	NULL
11	NULL
,	NULL
13	NULL
,	NULL
16	NULL
,	NULL
22	NULL
,	NULL
32	NULL
,	NULL
45	NULL
,	NULL
54	NULL
,	NULL
57	NULL
,	NULL
60	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
by	NULL
using	NULL
proteasome	NULL
inhibitors	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
the	NULL
phosphorylated	NULL
form	NULL
of	NULL
IxBa	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Unité	NULL
de	NULL
Biologie	NULL
Moléculaire	NULL
de	NULL
'Expression	NULL
Génique	NULL
,	NULL
Institut	NULL
Pasteur	NULL
,	NULL
25	NULL
rue	NULL
du	NULL
Dr	NULL
Roux	NULL
,	NULL
75724	NULL
Paris	NULL
Cedex	NULL
15	NULL
,	NULL
France	NULL
.	NULL

Phone	NULL
:	NULL
33	NULL
1	NULL
45	NULL
68	NULL
85	NULL
53	NULL
.	NULL

Fax	NULL
:	NULL
33	NULL
1	NULL
40	NULL
61	NULL
30	NULL
40	NULL
.	NULL

E-mail	NULL
:	NULL
aisracl	NULL
@	NULL
pasteur	NULL
fr	NULL
.	NULL

1441	NULL
remains	NULL
associated	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
proteolysis	NULL
step	NULL
is	NULL
absolutely	NULL
required	NULL
to	NULL
inactivate	NULL
IxBa	NULL
(	NULL
1	NULL
,	NULL
15	NULL
,	NULL
17	NULL
,	NULL
35	NULL
,	NULL
56	NULL
)	NULL
.	NULL

The	NULL
recent	NULL
cloning	NULL
of	NULL
IxBB	NULL
and	NULL
IxBg	NULL
has	NULL
not	NULL
yet	NULL
allowed	NULL
a	NULL
detailed	NULL
analysis	NULL
of	NULL
their	NULL
mode	NULL
of	NULL
inactivation	NULL
.	NULL

Nevertheless	NULL
,	NULL
like	NULL
IxBa	NULL
,	NULL
IxBB	NULL
and	NULL
IxBg	NULL
are	NULL
degraded	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
(	NULL
16	NULL
,	NULL
31	NULL
,	NULL
55	NULL
,	NULL
61	NULL
)	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
this	NULL
degradation	NULL
process	NULL
involves	NULL
the	NULL
proteasome	NULL
complex	NULL
and	NULL
requires	NULL
two	NULL
serine	NULL
residues	NULL
that	NULL
are	NULL
located	NULL
in	NULL
a	NULL
sequence	NULL
motif	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
Ser	NULL
32	NULL
and	NULL
36	NULL
of	NULL
IxBa	NULL
(	NULL
16	NULL
,	NULL
31	NULL
,	NULL
61	NULL
)	NULL
.	NULL

As	NULL
indicated	NULL
above	NULL
,	NULL
a	NULL
large	NULL
number	NULL
of	NULL
stimuli	NULL
are	NULL
able	NULL
to	NULL
activate	NULL
NF-kB	NULL
.	NULL

However	NULL
,	NULL
if	NULL
the	NULL
final	NULL
target	NULL
of	NULL
several	NULL
of	NULL
them	NULL
is	NULL
Ser	NULL
32	NULL
and	NULL
36	NULL
of	NULL
IxBa	NULL
,	NULL
suggesting	NULL
the	NULL
involvement	NULL
of	NULL
a	NULL
regulated	NULL
kinase	NULL
or	NULL
phosphatase	NULL
,	NULL
the	NULL
intermediate	NULL
steps	NULL
are	NULL
poorly	NULL
defined	NULL
.	NULL

Since	NULL
various	NULL
antioxidants	NULL
are	NULL
able	NULL
to	NULL
inhibit	NULL
NF-kB	NULL
activation	NULL
(	NULL
34	NULL
,	NULL
49	NULL
,	NULL
52	NULL
)	NULL
,	NULL
one	NULL
of	NULL
them	NULL
could	NULL
be	NULL
redox	NULL
regulated	NULL
.	NULL

Alternatively	NULL
,	NULL
oxidants	NULL
themselves	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
certain	NULL
cell	NULL
types	NULL
,	NULL
suggesting	NULL
that	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
ROI	NULL
)	NULL
,	NULL
such	NULL
as	NULL
superoxides	NULL
or	NULL
H,0	NULL
,	NULL
;	NULL
,	NULL
could	NULL
be	NULL
second	NULL
messengers	NULL
common	NULL
to	NULL
all	NULL
NF-kB	NULL
activators	NULL
(	NULL
47-49	NULL
)	NULL
.	NULL

By	NULL
analogy	NULL
with	NULL
procaryotic	NULL
or	NULL
lower	NULL
eucaryotic	NULL
systems	NULL
,	NULL
the	NULL
isolation	NULL
of	NULL
mammalian	NULL
cellular	NULL
mutants	NULL
,	NULL
allowing	NULL
a	NULL
genetic	NULL
analysis	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
process	NULL
,	NULL
would	NULL
be	NULL
very	NULL
useful	NULL
.	NULL

Such	NULL
a	NULL
mutant	NULL
,	NULL
the	NULL
murine	NULL
pre-B	NULL
70Z/3-derived	NULL
1.3E2	NULL
cell	NULL
line	NULL
,	NULL
was	NULL
isolated	NULL
several	NULL
years	NULL
ago	NULL
by	NULL
selecting	NULL
cells	NULL
unable	NULL
to	NULL
express	NULL
surface	NULL
immunoglobulin	NULL
M	NULL
after	NULL
LPS	NULL
treatment	NULL
(	NULL
29	NULL
)	NULL
.	NULL

When	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
by	NULL
LPS	NULL
or	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
was	NULL
tested	NULL
,	NULL
no	NULL
inducible	NULL
DNA-binding	NULL
activity	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Importantly	NULL
,	NULL
such	NULL
a	NULL
defect	NULL
was	NULL
not	NULL
a	NULL
result	NULL
of	NULL
a	NULL
problem	NULL
of	NULL
p50	NULL
or	NULL
relA	NULL
synthesis	NULL
since	NULL
,	NULL
when	NULL
the	NULL
detergent	NULL
deoxycholate	NULL
was	NULL
used	NULL
,	NULL
a	NULL
latent	NULL
form	NULL
of	NULL
1442	NULL
COURTOIS	NULL
ET	NULL
AL	NULL
.	NULL

NF-kB	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
cytoplasmic	NULL
compartment	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
recessive	NULL
nature	NULL
of	NULL
the	NULL
defect	NULL
was	NULL
demonstrated	NULL
by	NULL
fusing	NULL
1.3E2	NULL
with	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
70Z/3	NULL
.	NULL

The	NULL
resulting	NULL
hybrid	NULL
cell	NULL
was	NULL
able	NULL
to	NULL
activate	NULL
NF-kB	NULL
upon	NULL
stimulation	NULL
(	NULL
reference	NULL
29	NULL
and	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
characterized	NULL
the	NULL
1.3E2	NULL
cell	NULL
line	NULL
more	NULL
thoroughly	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
IxBa	NULL
,	NULL
IxBB	NULL
,	NULL
and	NULL
IxBg	NULL
are	NULL
not	NULL
degraded	NULL
in	NULL
response	NULL
to	NULL
a	NULL
large	NULL
number	NULL
of	NULL
stimuli	NULL
.	NULL

Moreover	NULL
,	NULL
in	NULL
the	NULL
case	NULL
of	NULL
IxBa	NULL
,	NULL
we	NULL
also	NULL
show	NULL
a	NULL
lack	NULL
of	NULL
induced	NULL
phosphorylation	NULL
on	NULL
Ser	NULL
32	NULL
and	NULL
36	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
1.3E2	NULL
represents	NULL
a	NULL
cellular	NULL
transduction	NULL
mutant	NULL
that	NULL
is	NULL
deficient	NULL
in	NULL
a	NULL
crucial	NULL
component	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
process	NULL
.	NULL

Such	NULL
a	NULL
component	NULL
appears	NULL
to	NULL
be	NULL
required	NULL
for	NULL
inducing	NULL
IxBa	NULL
,	NULL
IxBB	NULL
,	NULL
and	NULL
IxBg	NULL
degradation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
.	NULL

wt	NULL
702Z/3	NULL
and	NULL
1.3E2	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
and	NULL
50	NULL
M	NULL
B-mercaptocthanol	NULL
.	NULL

Stable	NULL
cell	NULL
lines	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
60	NULL
)	NULL
with	NULL
plasmids	NULL
Re/CMV-B-IxBa-wt	NULL
(	NULL
60	NULL
)	NULL
for	NULL
stable	NULL
cells	NULL
expressing	NULL
human	NULL
IxBa	NULL
(	NULL
hIxBa	NULL
)	NULL
,	NULL
Re/CMV-p105Rsa	NULL
(	NULL
24	NULL
,	NULL
36	NULL
)	NULL
for	NULL
cell	NULL
lines	NULL
expressing	NULL
hp50	NULL
,	NULL
Re/CMV-Flag-p65	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
J.	NULL
Didonato	NULL
)	NULL
for	NULL
cell	NULL
lines	NULL
expressing	NULL
Flag-p65	NULL
,	NULL
and	NULL
cDNA3BIxB-£45k	NULL
(	NULL
61	NULL
)	NULL
for	NULL
cell	NULL
lines	NULL
expressing	NULL
hIxBe	NULL
.	NULL

Reagents	NULL
.	NULL

LPS	NULL
,	NULL
PMA	NULL
,	NULL
poly	NULL
(	NULL
I-C	NULL
)	NULL
,	NULL
Taxol	NULL
,	NULL
and	NULL
p-sorbitol	NULL
were	NULL
from	NULL
Sigma	NULL
.	NULL

Re-combinant	NULL
human	NULL
(	NULL
IL-1B	NULL
)	NULL
was	NULL
from	NULL
Biogen	NULL
(	NULL
Geneva	NULL
,	NULL
Switzer-land	NULL
)	NULL
.	NULL

Absence	NULL
of	NULL
endotoxin	NULL
contamination	NULL
in	NULL
all	NULL
these	NULL
reagents	NULL
,	NULL
except	NULL
LPS	NULL
,	NULL
was	NULL
checked	NULL
by	NULL
a	NULL
polymyxin	NULL
B	NULL
assay	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Antisera	NULL
.	NULL

The	NULL
following	NULL
rabbit	NULL
antisera	NULL
were	NULL
used	NULL
:	NULL
anti-p50	NULL
,	NULL
1141	NULL
and	NULL
1157	NULL
(	NULL
38	NULL
)	NULL
;	NULL
anti-p65	NULL
,	NULL
1226	NULL
(	NULL
38	NULL
)	NULL
;	NULL
$	NULL
5	NULL
(	NULL
30	NULL
)	NULL
;	NULL
anti-IxBB	NULL
(	NULL
55	NULL
)	NULL
and	NULL
30715	NULL
(	NULL
592	NULL
)	NULL
;	NULL
and	NULL
anti-I	NULL
«	NULL
Be	NULL
,	NULL
812	NULL
(	NULL
61	NULL
)	NULL
.	NULL

Mouse	NULL
monoclonal	NULL
antibodies	NULL
were	NULL
anti-Flag	NULL
(	NULL
IBl/Kodak	NULL
)	NULL
;	NULL
anti-myc	NULL
,	NULL
9E10	NULL
;	NULL
and	NULL
antiphosphotyrosine	NULL
,	NULL
4G10	NULL
(	NULL
UBI	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
cell	NULL
extracts	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
then	NULL
resuspended	NULL
at	NULL
10°	NULL
cells/10	NULL
pl	NULL
in	NULL
hypotonic	NULL
solution	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.8	NULL
]	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
2	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
(	NULL
DTT	NULL
)	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
10	NULL
mM	NULL
NaF	NULL
)	NULL
.	NULL

After	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
3	NULL
pl	NULL
of	NULL
10	NULL
%	NULL
Nonidet	NULL
P-40	NULL
was	NULL
added	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
centrifuged	NULL
in	NULL
a	NULL
microcentrifuge	NULL
for	NULL
20	NULL
s.	NULL
The	NULL
supernatant	NULL
,	NULL
containing	NULL
the	NULL
cytoplasmic	NULL
fraction	NULL
,	NULL
was	NULL
recovered	NULL
.	NULL

One	NULL
volume	NULL
of	NULL
2	NULL
%	NULL
Laemmli	NULL
buffer	NULL
containing	NULL
20	NULL
%	NULL
B-mercaptocthanol	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
sample	NULL
was	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
.	NULL

It	NULL
was	NULL
kept	NULL
at	NULL
-20°C	NULL
or	NULL
analyzed	NULL
immediately	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
pellet	NULL
was	NULL
briefly	NULL
washed	NULL
with	NULL
hypotonic	NULL
buffer	NULL
and	NULL
then	NULL
resuspended	NULL
in	NULL
40	NULL
l	NULL
of	NULL
extraction	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.8	NULL
]	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
300	NULL
mM	NULL
NaCl	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

After	NULL
a	NULL
30-min	NULL
incubation	NULL
on	NULL
ice	NULL
with	NULL
occasional	NULL
agitation	NULL
,	NULL
the	NULL
DNA	NULL
was	NULL
pelleted	NULL
by	NULL
centrifuging	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
supernatant	NULL
,	NULL
containing	NULL
the	NULL
nuclear	NULL
fraction	NULL
,	NULL
was	NULL
recovered	NULL
and	NULL
quickly	NULL
frozen	NULL
on	NULL
dry	NULL
ice	NULL
.	NULL

Samples	NULL
were	NULL
stored	NULL
at	NULL
-20°C	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
.	NULL

Proteins	NULL
from	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
fractionated	NULL
on	NULL
sodium	NULL
dodecyl	NULL
sulfate-10	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellu-lose	NULL
membranes	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
)	NULL
.	NULL

After	NULL
being	NULL
blocked	NULL
in	NULL
3	NULL
%	NULL
milk-PBS	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
incubated	NULL
in	NULL
0.3	NULL
%	NULL
milk/PBS	NULL
containing	NULL
a	NULL
1:1,000	NULL
dilution	NULL
of	NULL
the	NULL
relevant	NULL
antibody	NULL
.	NULL

When	NULL
the	NULL
4G10	NULL
antibody	NULL
was	NULL
used	NULL
,	NULL
5	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
instead	NULL
of	NULL
3	NULL
%	NULL
milk	NULL
was	NULL
used	NULL
.	NULL

After	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
washed	NULL
for	NULL
30	NULL
min	NULL
with	NULL
three	NULL
changes	NULL
in	NULL
0.05	NULL
%	NULL
Tween	NULL
20-PBS	NULL
.	NULL

Immobilized	NULL
antigen-antibody	NULL
conjugates	NULL
were	NULL
detected	NULL
with	NULL
horseradish	NULL
perox-idase-conjugated	NULL
donkey	NULL
anti-rabbit	NULL
or	NULL
anti-mouse	NULL
immunoglobulins	NULL
(	NULL
Biosys	NULL
)	NULL
in	NULL
0.3	NULL
%	NULL
milk-PBS	NULL
.	NULL

After	NULL
three	NULL
washes	NULL
in	NULL
0.05	NULL
%	NULL
Tween	NULL
20-PBS	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
analyzed	NULL
with	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
detection	NULL
system	NULL
(	NULL
ECL	NULL
;	NULL
Amer-sham	NULL
)	NULL
.	NULL

Immunoprecipitations	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
prepared	NULL
from	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
TNT	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
200	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
)	NULL
.	NULL

Antibody	NULL
(	NULL
3	NULL
to	NULL
5	NULL
pl	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
gently	NULL
rocked	NULL
at	NULL
4°C	NULL
for	NULL
1	NULL
h.	NULL
A	NULL
50-pl	NULL
volume	NULL
of	NULL
Pansorbin	NULL
(	NULL
Calbiochem	NULL
)	NULL
,	NULL
previously	NULL
equilibrated	NULL
in	NULL
TNT	NULL
,	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
incubation	NULL
was	NULL
continued	NULL
for	NULL
30	NULL
min	NULL
.	NULL

After	NULL
three	NULL
washes	NULL
in	NULL
TNT	NULL
(	NULL
30	NULL
s	NULL
in	NULL
a	NULL
microcentrifuge	NULL
)	NULL
,	NULL
the	NULL
Pansorbin	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
1X	NULL
Laemmli	NULL
buffer	NULL
,	NULL
containing	NULL
10	NULL
%	NULL
B-mercaptocthanol	NULL
,	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
to	NULL
recover	NULL
the	NULL
antigen-antibody	NULL
conjugate	NULL
.	NULL

After	NULL
being	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
fractionated	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
analyzed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
.	NULL

A	NULL
5-pl	NULL
volume	NULL
of	NULL
nuclear	NULL
extracts	NULL
was	NULL
added	NULL
to	NULL
15	NULL
pl	NULL
of	NULL
binding	NULL
buffer	NULL
[	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
final	NULL
]	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
and	NULL
0.5	NULL
ng	NULL
of	NULL
P-labeled	NULL
MHC-1	NULL
probe	NULL
(	NULL
36	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

For	NULL
super-shifting	NULL
experiments	NULL
,	NULL
extracts	NULL
were	NULL
preincubated	NULL
for	NULL
20	NULL
min	NULL
in	NULL
the	NULL
same	NULL
buffer	NULL
with	NULL
1	NULL
pl	NULL
of	NULL
antibody	NULL
before	NULL
the	NULL
probe	NULL
was	NULL
added	NULL
.	NULL

Samples	NULL
were	NULL
run	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.5	NULL
%	NULL
TBE	NULL
.	NULL

Transfection	NULL
and	NULL
luciferase	NULL
assays	NULL
.	NULL

Cells	NULL
were	NULL
transiently	NULL
transfected	NULL
by	NULL
a	NULL
modified	NULL
DEAE-dextran	NULL
method	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
washed	NULL
in	NULL
TBS	NULL
were	NULL
resuspended	NULL
at	NULL
10	NULL
``	NULL
cells/ml	NULL
in	NULL
TBS	NULL
containing	NULL
0.5	NULL
mg	NULL
of	NULL
DEAE-dextran	NULL
(	NULL
Pharmacia	NULL
)	NULL
per	NULL
ml	NULL
.	NULL

Then	NULL
1	NULL
g	NULL
of	NULL
Igx-lue	NULL
reporter	NULL
plasmid	NULL
(	NULL
36	NULL
)	NULL
,	NULL
or	NULL
total	NULL
DNA	NULL
when	NULL
several	NULL
plasmids	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
702/3	NULL
1.322	NULL
e	NULL
A-	NULL
n	NULL
ee	NULL
es	NULL
ees	NULL
-	NULL
IBC	NULL
I	NULL
0	NULL
20	NULL
40	NULL
60	NULL
0	NULL
20	NULL
40	NULL
60	NULL
(	NULL
mn	NULL
)	NULL
70Z/3	NULL
|	NULL
1.362	NULL
'	NULL
i	NULL
.	NULL

i	NULL
i	NULL
-p50/ReIA	NULL
-pS50/p50	NULL
0	NULL
30	NULL
60	NULL
120	NULL
240480	NULL
0	NULL
30	NULL
60	NULL
120	NULL
240	NULL
480	NULL
(	NULL
mn	NULL
)	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

LPS	NULL
does	NULL
not	NULL
induce	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
1.3E2	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
IxBa	NULL
levels	NULL
in	NULL
wt	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
following	NULL
exposure	NULL
to	NULL
15	NULL
ug	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
wt	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
following	NULL
exposure	NULL
to	NULL
15	NULL
pg	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
.	NULL

In	NULL
each	NULL
lane	NULL
,	NULL
nuclear	NULL
extracts	NULL
corresponding	NULL
to	NULL
approximately	NULL
0.5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
with	NULL
a	NULL
``	NULL
P-labeled	NULL
MHC1-derived	NULL
probe	NULL
.	NULL

The	NULL
protein	NULL
composition	NULL
of	NULL
the	NULL
two	NULL
inducible	NULL
complexes	NULL
was	NULL
determined	NULL
by	NULL
preincubating	NULL
the	NULL
extracts	NULL
with	NULL
antibodies	NULL
specifically	NULL
directed	NULL
against	NULL
relA	NULL
(	NULL
no	NULL
.	NULL

1226	NULL
)	NULL
or	NULL
p50	NULL
(	NULL
no	NULL
.	NULL

1157	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

were	NULL
used	NULL
,	NULL
was	NULL
added	NULL
per	NULL
10°	NULL
cells	NULL
.	NULL

After	NULL
45	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
diluted	NULL
with	NULL
10	NULL
volumes	NULL
of	NULL
TBS	NULL
,	NULL
centrifuged	NULL
,	NULL
and	NULL
resuspended	NULL
at	NULL
10°	NULL
cells/ml	NULL
in	NULL
10	NULL
%	NULL
FCS-RPML	NULL
After	NULL
incubation	NULL
at	NULL
37°C	NULL
for	NULL
24	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
4	NULL
to	NULL
6	NULL
h	NULL
and	NULL
finally	NULL
lysed	NULL
in	NULL
a	NULL
luciferase	NULL
buffer	NULL
(	NULL
25	NULL
mM	NULL
Tris-phosphate	NULL
[	NULL
pH	NULL
7.8	NULL
]	NULL
,	NULL
8	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
15	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

Luciferase	NULL
determination	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
a	NULL
Berthold	NULL
luminometer	NULL
.	NULL

Analysis	NULL
of	NULL
ROI	NULL
levels	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
(	NULL
FACS	NULL
)	NULL
.	NULL

Cells	NULL
(	NULL
10°	NULL
)	NULL
in	NULL
PBS	NULL
were	NULL
incubated	NULL
with	NULL
5	NULL
M	NULL
2',7'-dichlorofluorescein	NULL
(	NULL
DCFH	NULL
)	NULL
diac-etate	NULL
(	NULL
Fluka	NULL
)	NULL
in	NULL
dimethylformamide	NULL
at	NULL
37°C	NULL
.	NULL

Aliquots	NULL
of	NULL
10°	NULL
cells	NULL
were	NULL
then	NULL
scanned	NULL
on	NULL
a	NULL
FACSSORT	NULL
(	NULL
Beckton	NULL
Dickinson	NULL
)	NULL
with	NULL
excitation	NULL
and	NULL
emission	NULL
settings	NULL
of	NULL
495	NULL
and	NULL
525	NULL
nm	NULL
,	NULL
respectively	NULL
(	NULL
6	NULL
)	NULL
.	NULL

RESULTS	NULL
LPS	NULL
does	NULL
not	NULL
induce	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
1.3E2	NULL
.	NULL

It	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
that	NULL
degradation	NULL
of	NULL
IxBa	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
NF-kB	NULL
activation	NULL
.	NULL

We	NULL
therefore	NULL
analyzed	NULL
the	NULL
fate	NULL
of	NULL
IxBa	NULL
after	NULL
stimulation	NULL
by	NULL
LPS	NULL
in	NULL
the	NULL
1.3E2	NULL
mutant	NULL
cell	NULL
line	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
no	NULL
obvious	NULL
degradation	NULL
of	NULL
IxBa	NULL
was	NULL
detected	NULL
after	NULL
1	NULL
h	NULL
whereas	NULL
the	NULL
same	NULL
treatment	NULL
of	NULL
wt	NULL
70Z	NULL
,	NULL
/3	NULL
resulted	NULL
in	NULL
complete	NULL
disappearance	NULL
of	NULL
IxBa	NULL
within	NULL
40	NULL
min	NULL
.	NULL

Concomitantly	NULL
,	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
any	NULL
p50/relA	NULL
,	NULL
p50/p50	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
or	NULL
c-rel/relA	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
accumulation	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
EMSA	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
,	NULL
activation	NULL
of	NULL
a	NULL
NF-	NULL
«	NULL
B-driven	NULL
reporter	NULL
plasmid	NULL
appeared	NULL
strongly	NULL
reduced	NULL
(	NULL
see	NULL
below	NULL
,	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Recent	NULL
reports	NULL
have	NULL
demonstrated	NULL
that	NULL
stimulation	NULL
of	NULL
various	NULL
cell	NULL
lines	NULL
with	NULL
LPS	NULL
,	NULL
PMA	NULL
,	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
induces	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
on	NULL
Ser	NULL
32	NULL
and	NULL
36	NULL
and	NULL
that	NULL
such	NULL
a	NULL
modification	NULL
targets	NULL
the	NULL
inhibitor	NULL
for	NULL
rapid	NULL
degradation	NULL
by	NULL
the	NULL
proteasome	NULL
.	NULL

Although	NULL
IxBa-induced	NULL
phosphorylation	NULL
is	NULL
tran-sient	NULL
,	NULL
it	NULL
can	NULL
be	NULL
detected	NULL
by	NULL
using	NULL
proteasome	NULL
inhibitors	NULL
which	NULL
stabilize	NULL
phosphorylated	NULL
IxBa	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
the	NULL
human	NULL
protein	NULL
,	NULL
an	NULL
upshifted	NULL
band	NULL
can	NULL
be	NULL
easily	NULL
detected	NULL
after	NULL
migration	NULL
on	NULL
a	NULL
denaturing	NULL
SDS-polyacrylamide	NULL
gel	NULL
.	NULL

Stable	NULL
wt	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
clones	NULL
expressing	NULL
hlkBa	NULL
(	NULL
hereafter	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
Zha	NULL
and	NULL
Eha	NULL
cell	NULL
lines	NULL
,	NULL
respectively	NULL
)	NULL
were	NULL
therefore	NULL
prepared	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
and	NULL
checked	NULL
first	NULL
for	NULL
the	NULL
response	NULL
of	NULL
the	NULL
exogenous	NULL
hlkBa	NULL
«	NULL
to	NULL
LPS	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
hlkBa	NULL
responded	NULL
identically	NULL
to	NULL
the	NULL
endogenous	NULL
mlkBa	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
IxBa	NULL
was	NULL
not	NULL
mutated	NULL
in	NULL
1.3E2	NULL
.	NULL

Preincubation	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
with	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
aLLnL	NULL
,	NULL
before	NULL
LPS	NULL
treatment	NULL
,	NULL
allowed	NULL
the	NULL
detection	NULL
of	NULL
a	NULL
retarded	NULL
phosphorylated	NULL
hIxBa	NULL
band	NULL
in	NULL
Zha	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
Eha	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Although	NULL
this	NULL
observation	NULL
was	NULL
strongly	NULL
suggestive	NULL
of	NULL
a	NULL
defect	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
A	NULL
B	NULL
Z	NULL
Zho	NULL
Eho	NULL
E	NULL
Zha	NULL
|	NULL
Eho	NULL
:	NULL
hikBa	NULL
:	NULL
\_	NULL
5	NULL
ar	NULL
hixBor	NULL
me	NULL
.	NULL

--	NULL
-	NULL
``	NULL
manly	NULL
y	NULL
Wmlem	NULL
0	NULL
15	NULL
30	NULL
60	NULL
0	NULL
15	NULL
30	NULL
60	NULL
(	NULL
mn	NULL
)	NULL
C	NULL
@	NULL
hixBa	NULL
:	NULL
Zha	NULL
.	NULL

|	NULL
Eho	NULL
:	NULL
Misti	NULL
,	NULL
-	NULL
ne	NULL
e	NULL
ee	NULL
aes	NULL
mikBa	NULL
**	NULL
10	NULL
20	NULL
3	NULL
40	NULL
S	NULL
60	NULL
7	NULL
8	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

LPS	NULL
,	NULL
PMA	NULL
,	NULL
and	NULL
IL-1	NULL
do	NULL
not	NULL
induce	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
in	NULL
1.3E2	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
cell	NULL
lines	NULL
stably	NULL
expressing	NULL
hIxBa	NULL
.	NULL

Lanes	NULL
:	NULL
Z	NULL
,	NULL
wt	NULL
70Z/3	NULL
cells	NULL
;	NULL
Zha	NULL
,	NULL
70Z/3	NULL
cells	NULL
expressing	NULL
hlxBa	NULL
;	NULL
E	NULL
,	NULL
1.3E2	NULL
cells	NULL
;	NULL
Eha	NULL
,	NULL
1.3E2	NULL
cells	NULL
expressing	NULL
hIxBa	NULL
.	NULL

The	NULL
relative	NULL
migrations	NULL
of	NULL
exogenous	NULL
hIxBa	NULL
«	NULL
and	NULL
endogenous	NULL
murine	NULL
IxBa	NULL
(	NULL
mIxBa	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
IxBa	NULL
levels	NULL
in	NULL
Zha	NULL
and	NULL
Eha	NULL
following	NULL
exposure	NULL
to	NULL
15	NULL
ug	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Analysis	NULL
of	NULL
hIxBa-induced	NULL
phosphorylation	NULL
in	NULL
Zhe	NULL
and	NULL
Eha	NULL
cell	NULL
lines	NULL
.	NULL

Cells	NULL
were	NULL
preincubated	NULL
for	NULL
45	NULL
min	NULL
with	NULL
100	NULL
M	NULL
aLLnL	NULL
and	NULL
then	NULL
left	NULL
untreated	NULL
for	NULL
1	NULL
h	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
15	NULL
g	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
)	NULL
,	NULL
100	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
,	NULL
or	NULL
20	NULL
ng	NULL
of	NULL
IL-1	NULL
per	NULL
ml	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
from	NULL
Zhe	NULL
and	NULL
Eha	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

The	NULL
relative	NULL
migrations	NULL
of	NULL
phosphorylated	NULL
hIxBa	NULL
«	NULL
(	NULL
P-hIxBa	NULL
)	NULL
,	NULL
hi	NULL
«	NULL
xBa	NULL
and	NULL
mIxBa	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

located	NULL
at	NULL
a	NULL
step	NULL
preceding	NULL
IxBa	NULL
phosphorylation	NULL
,	NULL
we	NULL
could	NULL
not	NULL
formally	NULL
dismiss	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
mutation	NULL
in	NULL
1.3E2	NULL
at	NULL
the	NULL
level	NULL
of	NULL
p50	NULL
or	NULL
relA	NULL
that	NULL
would	NULL
affect	NULL
the	NULL
phosphorylation	NULL
process	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
interaction	NULL
of	NULL
a	NULL
kinase	NULL
with	NULL
p50	NULL
or	NULL
relA	NULL
B	NULL
A	NULL
nuC	NULL
Z	NULL
Zh50	NULL
E	NULL
EhSO	NULL
m	NULL
conman	NULL
a-hp50	NULL
blot	NULL
nut	NULL
D	NULL
C	NULL
[	NULL
119	NULL
(	NULL
e	NULL
Z	NULL
ZrelA*	NULL
E	NULL
ErelA*	NULL
gm	NULL
omens	NULL
<	NULL
Gmurs	NULL
a-Flag	NULL
I.P	NULL
.	NULL

a-relA	NULL
blot	NULL
nuc	NULL
NF-kB	NULL
ACTIVATION-DEFICIENT	NULL
CELL	NULL
LINE	NULL
-	NULL
1443	NULL
could	NULL
be	NULL
required	NULL
to	NULL
phosphorylate	NULL
IxBa	NULL
.	NULL

To	NULL
solve	NULL
this	NULL
prob-lem	NULL
,	NULL
we	NULL
prepared	NULL
stable	NULL
wt	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
cell	NULL
lines	NULL
expressing	NULL
human	NULL
p50	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
or	NULL
tagged	NULL
murine	NULL
relA	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
and	NULL
compared	NULL
the	NULL
fate	NULL
of	NULL
these	NULL
exogenously	NULL
introduced	NULL
proteins	NULL
to	NULL
that	NULL
of	NULL
their	NULL
endogenous	NULL
counterparts	NULL
.	NULL

An	NULL
exogenous	NULL
human	NULL
p50	NULL
protein	NULL
stably	NULL
introduced	NULL
either	NULL
into	NULL
wt	NULL
70Z/3	NULL
or	NULL
into	NULL
1.3E2	NULL
cells	NULL
behaved	NULL
similarly	NULL
to	NULL
the	NULL
endogenous	NULL
p50	NULL
;	NULL
i.e	NULL
.	NULL

,	NULL
it	NULL
translocated	NULL
into	NULL
the	NULL
nucleus	NULL
of	NULL
70Z/3	NULL
after	NULL
LPS	NULL
stimulation	NULL
whereas	NULL
it	NULL
did	NULL
not	NULL
in	NULL
1.3E2	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
indicated	NULL
that	NULL
p50	NULL
was	NULL
fully	NULL
functional	NULL
in	NULL
1.3E2	NULL
.	NULL

A	NULL
similar	NULL
conclusion	NULL
was	NULL
reached	NULL
for	NULL
relA	NULL
by	NULL
using	NULL
a	NULL
tagged	NULL
protein	NULL
and	NULL
performing	NULL
the	NULL
same	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
:	NULL
LPS	NULL
treatment	NULL
of	NULL
wt	NULL
70Z	NULL
%	NULL
,	NULL
/3	NULL
expressing	NULL
Flag-relA	NULL
resulted	NULL
in	NULL
a	NULL
translocation	NULL
of	NULL
Flag-relA	NULL
into	NULL
the	NULL
nucleus	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Flag-relA	NULL
expressed	NULL
in	NULL
1.3E2	NULL
did	NULL
not	NULL
respond	NULL
to	NULL
LPS	NULL
.	NULL

Multiple	NULL
stimuli	NULL
are	NULL
unable	NULL
to	NULL
activate	NULL
NF-KB	NULL
in	NULL
1.3E2	NULL
.	NULL

Since	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
LPS	NULL
,	NULL
a	NULL
large	NULL
number	NULL
of	NULL
stimuli	NULL
are	NULL
able	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
70	NULL
%	NULL
/3	NULL
,	NULL
we	NULL
analyzed	NULL
their	NULL
effect	NULL
on	NULL
1.3E2	NULL
cells	NULL
.	NULL

As	NULL
with	NULL
LPS	NULL
,	NULL
we	NULL
monitored	NULL
IxBa	NULL
degradation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
induction	NULL
of	NULL
nuclear	NULL
NF-kB	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
and	NULL
NF-KB	NULL
transcriptional	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Stimuli	NULL
like	NULL
PMA	NULL
,	NULL
IL-1	NULL
,	NULL
double-stranded	NULL
RNA	NULL
(	NULL
dsRNA	NULL
)	NULL
,	NULL
and	NULL
Taxol	NULL
(	NULL
26	NULL
)	NULL
were	NULL
unable	NULL
to	NULL
induce	NULL
IxBa	NULL
degradation	NULL
and	NULL
induce	NULL
NF-kB	NULL
binding	NULL
or	NULL
transcriptional	NULL
activities	NULL
in	NULL
1.3E2	NULL
.	NULL

Moreover	NULL
,	NULL
an	NULL
induced	NULL
phosphorylated	NULL
hIxBa	NULL
band	NULL
could	NULL
not	NULL
be	NULL
observed	NULL
in	NULL
the	NULL
Eha	NULL
Z	NULL
l	NULL
E	NULL
«	NULL
wite	NULL
«	NULL
-p50	NULL
blot	NULL
-o	NULL
o	NULL
$	NULL
o-	NULL
+0	NULL
Zh50	NULL
I	NULL
Eh50	NULL
win	NULL
-	NULL
-	NULL
<	NULL
e	NULL
a-hp50	NULL
blot	NULL
=o	NULL
ok	NULL
o-	NULL
o	NULL
$	NULL
_	NULL
(	NULL
LPs	NULL
)	NULL
Z	NULL
I	NULL
E	NULL
-	NULL
a-relA	NULL
blot	NULL
=-	NULL
o	NULL
o=	NULL
O+	NULL
-	NULL
(	NULL
LPS	NULL
)	NULL
ZrelA*	NULL
|EreIA*	NULL
Tey	NULL
f	NULL
WMJ	NULL
-	NULL
o-Flag	NULL
I.P	NULL
.	NULL

|	NULL
Whi	NULL
u	NULL
-	NULL
»	NULL
w	NULL
a-relA	NULL
blot	NULL
-o	NULL
op	NULL
o-	NULL
of	NULL
0	NULL
(	NULL
LP§	NULL
)	NULL
FIG	NULL
.	NULL

3.	NULL
p50	NULL
or	NULL
relA	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
are	NULL
functional	NULL
in	NULL
1.3E2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
cell	NULL
lines	NULL
stably	NULL
expressing	NULL
human	NULL
p50	NULL
(	NULL
bp50	NULL
)	NULL
.	NULL

Lanes	NULL
:	NULL
Z	NULL
,	NULL
wt	NULL
70Z/3	NULL
cells	NULL
;	NULL
Zh50	NULL
,	NULL
70Z/3	NULL
cells	NULL
expressing	NULL
hp50	NULL
;	NULL
E	NULL
,	NULL
1.3E2	NULL
cells	NULL
;	NULL
Eh50	NULL
,	NULL
1.3E2	NULL
cells	NULL
expressing	NULL
hp50	NULL
.	NULL

The	NULL
antibody	NULL
used	NULL
(	NULL
no	NULL
.	NULL

1141	NULL
)	NULL
specifically	NULL
recognizes	NULL
hp50	NULL
but	NULL
does	NULL
not	NULL
recognize	NULL
murine	NULL
p50	NULL
(	NULL
mp50	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nuclear	NULL
accumulation	NULL
of	NULL
hp50	NULL
in	NULL
70Z/3	NULL
but	NULL
not	NULL
in	NULL
1.3E2	NULL
following	NULL
LPS	NULL
stimulation	NULL
.	NULL

A	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
endogenous	NULL
mp50	NULL
(	NULL
with	NULL
antiserum	NULL
1157	NULL
)	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
exogenous	NULL
hp50	NULL
(	NULL
with	NULL
antiserum	NULL
1141	NULL
)	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
was	NULL
carried	NULL
out	NULL
on	NULL
nuclear	NULL
extracts	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
cell	NULL
lines	NULL
stably	NULL
expressing	NULL
Flag-relA	NULL
(	NULL
relA*	NULL
)	NULL
.	NULL

Lanes	NULL
:	NULL
Z	NULL
,	NULL
wt	NULL
70Z/3	NULL
cells	NULL
;	NULL
ZrelA*	NULL
,	NULL
70Z/3	NULL
cells	NULL
expressing	NULL
relA*	NULL
;	NULL
E	NULL
,	NULL
1.3E2	NULL
cells	NULL
;	NULL
ErelA*	NULL
,	NULL
1.3E2	NULL
cells	NULL
expressing	NULL
relA*	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
first	NULL
immunoprecipitated	NULL
with	NULL
an	NULL
anti-Flag	NULL
antibody	NULL
and	NULL
then	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
an	NULL
anti-relA	NULL
antibody	NULL
(	NULL
no	NULL
.	NULL

1226	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Nuclear	NULL
accumulation	NULL
of	NULL
relA*	NULL
in	NULL
70Z/3	NULL
but	NULL
not	NULL
in	NULL
1.3E2	NULL
following	NULL
LPS	NULL
stimulation	NULL
.	NULL

A	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
endogenous	NULL
murine	NULL
relA	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
exogenous	NULL
relA*	NULL
(	NULL
with	NULL
antiserum	NULL
1226	NULL
)	NULL
after	NULL
immunoprecipitation	NULL
with	NULL
anti-Flag	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
was	NULL
carried	NULL
out	NULL
on	NULL
nuclear	NULL
extracts	NULL
.	NULL

1444	NULL
COURTOIS	NULL
ET	NULL
AL	NULL
.	NULL

702/3	NULL
|	NULL
1.362	NULL
PMA	NULL
===	NULL
7-7	NULL
~~	NULL
me	NULL
.	NULL

1-1	NULL
-	NULL
owe	NULL
7o2/3	NULL
1.362	NULL
ds	NULL
RNA	NULL
___	NULL
___	NULL
__	NULL
mame	NULL
«	NULL
«	NULL
-	NULL
Cal	NULL
.	NULL

wie	NULL
ice	NULL
Se	NULL
Sorb	NULL
.	NULL

0	NULL
20	NULL
40	NULL
60	NULL
0	NULL
20	NULL
40	NULL
60	NULL
(	NULL
mn	NULL
)	NULL
0	NULL
20	NULL
40	NULL
60	NULL
0	NULL
20	NULL
40	NULL
60	NULL
(	NULL
mn	NULL
)	NULL
Taxol	NULL
_	NULL
__	NULL
so	NULL
0	NULL
30	NULL
60	NULL
0	NULL
30	NULL
60	NULL
(	NULL
mn	NULL
)	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Several	NULL
different	NULL
stimuli	NULL
do	NULL
not	NULL
induce	NULL
IxBa	NULL
degradation	NULL
in	NULL
1.3E2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
IxBa	NULL
levels	NULL
in	NULL
wt	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
following	NULL
exposure	NULL
to	NULL
100	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
,	NULL
20	NULL
ng	NULL
of	NULL
IL-1	NULL
per	NULL
ml	NULL
,	NULL
0.1	NULL
mg	NULL
of	NULL
poly	NULL
(	NULL
I-C	NULL
)	NULL
per	NULL
ml	NULL
,	NULL
or	NULL
50	NULL
M	NULL
Taxol	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Same	NULL
analysis	NULL
,	NULL
with	NULL
300	NULL
nM	NULL
calyculin	NULL
A	NULL
(	NULL
Cal	NULL
.	NULL
)	NULL

or	NULL
0.4	NULL
M	NULL
sorbitol	NULL
(	NULL
Sorb	NULL
.	NULL
)	NULL

.	NULL

clone	NULL
following	NULL
treatment	NULL
with	NULL
PMA	NULL
or	NULL
IL-1	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
whereas	NULL
it	NULL
was	NULL
clearly	NULL
detected	NULL
in	NULL
Zha	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
two	NULL
phosphatase	NULL
inhibitors	NULL
,	NULL
calyculin	NULL
A	NULL
and	NULL
okadaic	NULL
acid	NULL
,	NULL
as	NULL
well	NULL
as	NULL
hyperosmotic	NULL
shock	NULL
with	NULL
0.4	NULL
M	NULL
sorbitol	NULL
(	NULL
14	NULL
)	NULL
,	NULL
were	NULL
able	NULL
to	NULL
activate	NULL
NF-KB	NULL
in	NULL
1.3E2	NULL
,	NULL
although	NULL
the	NULL
rate	NULL
of	NULL
IxBa	NULL
degradation	NULL
by	NULL
sorbitol	NULL
was	NULL
somewhat	NULL
lower	NULL
than	NULL
in	NULL
70Z/3	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
use	NULL
of	NULL
calyculin	NULL
A	NULL
allowed	NULL
us	NULL
to	NULL
also	NULL
show	NULL
that	NULL
in	NULL
the	NULL
mutant	NULL
cell	NULL
line	NULL
,	NULL
the	NULL
degradation	NULL
step	NULL
per	NULL
se	NULL
was	NULL
fully	NULL
functional	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
proteasome	NULL
inhibitor	NULL
aLLnL	NULL
blocked	NULL
IxBa	NULL
degradation	NULL
induced	NULL
by	NULL
this	NULL
reagent	NULL
in	NULL
both	NULL
wt	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
indicated	NULL
above	NULL
,	NULL
IxBa	NULL
degradation	NULL
triggered	NULL
by	NULL
LPS	NULL
,	NULL
PMA	NULL
,	NULL
or	NULL
IL-1	NULL
requires	NULL
inducible	NULL
phosphorylation	NULL
on	NULL
Ser	NULL
32/36	NULL
,	NULL
a	NULL
step	NULL
that	NULL
is	NULL
sensitive	NULL
to	NULL
the	NULL
antioxidant	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
tested	NULL
the	NULL
Ser	NULL
32/36	NULL
requirement	NULL
and	NULL
the	NULL
sensitivity	NULL
to	NULL
PDTC	NULL
of	NULL
the	NULL
stimuli	NULL
that	NULL
were	NULL
still	NULL
able	NULL
to	NULL
activate	NULL
NF-kB	NULL
in	NULL
1.3E2	NULL
.	NULL

Using	NULL
a	NULL
70Z/3	NULL
cell	NULL
line	NULL
stably	NULL
expressing	NULL
a	NULL
human	NULL
IxBa	NULL
doubly	NULL
mutated	NULL
on	NULL
Ser	NULL
32	NULL
and	NULL
36	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
LPS	NULL
,	NULL
PMA	NULL
,	NULL
IL-1	NULL
,	NULL
and	NULL
Taxol	NULL
,	NULL
calyculin	NULL
A	NULL
was	NULL
unable	NULL
to	NULL
induce	NULL
degradation	NULL
of	NULL
the	NULL
mutant	NULL
IxBa	NULL
70273	NULL
|	NULL
1.3E2	NULL
_	NULL
SO/relA	NULL
(	NULL
MA	NULL
.	NULL

I	NULL
B	NULL
ﬂ	NULL
-	NULL
50/50	NULL
0	NULL
15	NULL
30	NULL
60	NULL
‘	NULL
IZOIO	NULL
15	NULL
30	NULL
60	NULL
120	NULL
(	NULL
mn	NULL
)	NULL
IL-1	NULL
Gwen	NULL
une	NULL
-	NULL
50/relA	NULL
an	NULL
.	NULL

nen	NULL
-	NULL
50/50	NULL
<	NULL
dnnet	NULL
Gone	NULL
--	NULL
50/relA	NULL
ds	NULL
RNA	NULL
|	NULL
up	NULL
my	NULL
fk	NULL
1	NULL
)	NULL
wan	NULL
wat	NULL
W	NULL
bas	NULL
-	NULL
50/50	NULL
e	NULL
-	NULL
50/relA	NULL
Taxol	NULL
we	NULL
mg	NULL
s	NULL
Cseunn	NULL
A	NULL
'	NULL
a	NULL
-	NULL
50/relA	NULL
alyculin	NULL
fl	NULL
noun	NULL
-	NULL
so/50	NULL
0	NULL
15	NULL
30	NULL
sol	NULL
0	NULL
15	NULL
30	NULL
60	NULL
(	NULL
mn	NULL
)	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Defective	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
1.3E2	NULL
.	NULL

Induction	NULL
of	NULL
NF-	NULL
«	NULL
B-binding	NULL
activity	NULL
in	NULL
wt	NULL
70Z	NULL
,	NULL
/3	NULL
and	NULL
1.3E2	NULL
,	NULL
following	NULL
exposure	NULL
to	NULL
100	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
,	NULL
20	NULL
ng	NULL
of	NULL
IL-1	NULL
per	NULL
ml	NULL
,	NULL
0.1	NULL
mg	NULL
of	NULL
poly	NULL
(	NULL
I-C	NULL
)	NULL
per	NULL
ml	NULL
,	NULL
50	NULL
wM	NULL
Taxol	NULL
,	NULL
or	NULL
300	NULL
nM	NULL
calyculin	NULL
A	NULL
was	NULL
analyzed	NULL
by	NULL
EMSA	NULL
,	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

Note	NULL
the	NULL
unusual	NULL
migration	NULL
of	NULL
both	NULL
p50-relA	NULL
and	NULL
p50-p50	NULL
heterodimers	NULL
when	NULL
calyculin	NULL
A	NULL
was	NULL
used	NULL
(	NULL
see	NULL
the	NULL
text	NULL
for	NULL
an	NULL
explanation	NULL
)	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

molecule	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
dsRNA	NULL
,	NULL
no	NULL
unambiguous	NULL
involvement	NULL
of	NULL
Ser	NULL
32/36	NULL
was	NULL
demonstrated	NULL
,	NULL
due	NULL
to	NULL
the	NULL
weakness	NULL
of	NULL
the	NULL
response	NULL
to	NULL
this	NULL
stimulus	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Concerning	NULL
hyperosmotic	NULL
shock	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
sorbitol	NULL
does	NULL
not	NULL
induce	NULL
IxBa	NULL
degradation	NULL
through	NULL
Ser	NULL
32/36	NULL
in	NULL
70Z/3	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
70Z/3	NULL
cells	NULL
with	NULL
the	NULL
antioxidant	NULL
PDTC	NULL
could	NULL
inhibit	NULL
IxBa	NULL
degradation	NULL
induced	NULL
by	NULL
all	NULL
the	NULL
stimuli	NULL
tested	NULL
except	NULL
for	NULL
calyculin	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
and	NULL
hyperosmotic	NULL
shock	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
while	NULL
calyculin	NULL
A	NULL
requires	NULL
Ser	NULL
32/36	NULL
for	NULL
degrada-tion	NULL
,	NULL
both	NULL
calyculin	NULL
A	NULL
and	NULL
osmotic	NULL
shock	NULL
are	NULL
insensitive	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
PDTC	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
stimuli	NULL
that	NULL
are	NULL
able	NULL
to	NULL
activate	NULL
NF-kB	NULL
in	NULL
1.3E2	NULL
do	NULL
not	NULL
use	NULL
the	NULL
redox-sensitive	NULL
IxBa	NULL
degradation	NULL
pathway	NULL
.	NULL

The	NULL
viral	NULL
transactivator	NULL
Tax	NULL
can	NULL
activate	NULL
NF-KB	NULL
in	NULL
1.3E2	NULL
.	NULL

The	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
-derived	NULL
Tax	NULL
protein	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
various	NULL
cells	NULL
(	NULL
5	NULL
,	NULL
27	NULL
,	NULL
41	NULL
)	NULL
,	NULL
but	NULL
the	NULL
way	NULL
it	NULL
operates	NULL
remains	NULL
unclear	NULL
.	NULL

Although	NULL
some	NULL
authors	NULL
have	NULL
reported	NULL
that	NULL
Tax	NULL
acts	NULL
by	NULL
inducing	NULL
IxBa	NULL
degradation	NULL
through	NULL
Ser	NULL
32	NULL
and	NULL
36	NULL
phosphorylation	NULL
(	NULL
23	NULL
,	NULL
28	NULL
,	NULL
53	NULL
)	NULL
,	NULL
we	NULL
have	NULL
proposed	NULL
that	NULL
it	NULL
could	NULL
also	NULL
work	NULL
independently	NULL
of	NULL
IxBa	NULL
,	NULL
most	NULL
probably	NULL
by	NULL
releasing	NULL
NF-kB	NULL
subunits	NULL
retained	NULL
in	NULL
the	NULL
cytoplasm	NULL
by	NULL
the	NULL
p105	NULL
precursor	NULL
of	NULL
p50	NULL
(	NULL
36	NULL
)	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
idea	NULL
,	NULL
it	NULL
has	NULL
recently	NULL
been	NULL
reported	NULL
that	NULL
Tax	NULL
was	NULL
able	NULL
to	NULL
increase	NULL
the	NULL
processing	NULL
of	NULL
p105	NULL
by	NULL
interacting	NULL
both	NULL
with	NULL
this	NULL
precursor	NULL
and	NULL
with	NULL
two	NULL
different	NULL
subunits	NULL
of	NULL
the	NULL
proteasome	NULL
,	NULL
HsN3	NULL
and	NULL
HC9	NULL
(	NULL
40	NULL
)	NULL
.	NULL

In	NULL
70Z/3	NULL
cells	NULL
,	NULL
cotransfection	NULL
of	NULL
a	NULL
NF-	NULL
«	NULL
B	NULL
reporter	NULL
plasmid	NULL
with	NULL
a	NULL
Tax	NULL
expression	NULL
vector	NULL
resulted	NULL
in	NULL
a	NULL
five-	NULL
to	NULL
eightfold	NULL
increase	NULL
in	NULL
luciferase	NULL
production	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
level	NULL
of	NULL
induction	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
1.3E2	NULL
,	NULL
suggesting	NULL
that	NULL
Tax	NULL
does	NULL
not	NULL
use	NULL
the	NULL
pathway	NULL
that	NULL
is	NULL
deficient	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
.	NULL

IBB	NULL
and	NULL
IxBe	NULL
are	NULL
also	NULL
resistant	NULL
to	NULL
degradation	NULL
in	NULL
1.3E2	NULL
.	NULL

The	NULL
recent	NULL
cloning	NULL
of	NULL
two	NULL
new	NULL
IxB	NULL
molecules	NULL
,	NULL
IxBB	NULL
and	NULL
IxBg	NULL
(	NULL
55	NULL
,	NULL
61	NULL
)	NULL
,	NULL
prompted	NULL
us	NULL
to	NULL
analyze	NULL
their	NULL
fate	NULL
in	NULL
wt	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
results	NULL
obtained	NULL
by	NULL
Thompson	NULL
et	NULL
al	NULL
.	NULL

(	NULL
55	NULL
)	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
show	NULL
that	NULL
IxBB	NULL
could	NULL
be	NULL
degraded	NULL
not	NULL
only	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
but	NULL
also	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
,	NULL
IL-1	NULL
,	NULL
Taxol	NULL
,	NULL
and	NULL
calyculin	NULL
A	NULL
in	NULL
70Z/3	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
have	NULL
confirmed	NULL
that	NULL
this	NULL
corresponds	NULL
to	NULL
a	NULL
bona	NULL
fide	NULL
difference	NULL
between	NULL
two	NULL
70Z/3	NULL
clones	NULL
.	NULL

When	NULL
we	NULL
analyzed	NULL
1.3E2	NULL
,	NULL
we	NULL
found	NULL
that	NULL
all	NULL
these	NULL
stimuli	NULL
were	NULL
unable	NULL
to	NULL
induce	NULL
IxBB	NULL
degradation	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
only	NULL
difference	NULL
that	NULL
we	NULL
noticed	NULL
between	NULL
the	NULL
fates	NULL
of	NULL
IxBB	NULL
and	NULL
IxBa	NULL
in	NULL
1.3E2	NULL
was	NULL
in	NULL
response	NULL
to	NULL
calyculin	NULL
A	NULL
.	NULL

Nevertheless	NULL
,	NULL
when	NULL
we	NULL
tested	NULL
the	NULL
effect	NULL
of	NULL
PDTC	NULL
on	NULL
IxBB	NULL
degradation	NULL
induced	NULL
by	NULL
this	NULL
stimulus	NULL
,	NULL
we	NULL
observed	NULL
an	NULL
inhibitory	NULL
effect	NULL
that	NULL
had	NULL
not	NULL
been	NULL
noticed	NULL
with	NULL
IxBa	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

PDTC	NULL
was	NULL
also	NULL
inhibitory	NULL
for	NULL
IxBB	NULL
degradation	NULL
induced	NULL
by	NULL
LPS	NULL
,	NULL
PMA	NULL
,	NULL
and	NULL
Taxol	NULL
in	NULL
wt	NULL
70Z/3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Concerning	NULL
IxBg	NULL
,	NULL
a	NULL
more	NULL
limited	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
but	NULL
revealed	NULL
important	NULL
information	NULL
.	NULL

Since	NULL
endogenous	NULL
IxBg	NULL
was	NULL
difficult	NULL
to	NULL
detect	NULL
in	NULL
70Z/3	NULL
,	NULL
we	NULL
prepared	NULL
stable	NULL
wt	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
cell	NULL
lines	NULL
expressing	NULL
a	NULL
myc-tagged	NULL
IxBg	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
whereas	NULL
LPS	NULL
was	NULL
able	NULL
to	NULL
induce	NULL
degradation	NULL
of	NULL
tagged	NULL
IxBg	NULL
,	NULL
no	NULL
such	NULL
degradation	NULL
was	NULL
seen	NULL
in	NULL
1.3E2	NULL
.	NULL

A	NULL
similar	NULL
result	NULL
was	NULL
obtained	NULL
with	NULL
PMA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
that	NULL
of	NULL
IxBa	NULL
,	NULL
the	NULL
degradation	NULL
of	NULL
IxBB	NULL
and	NULL
IxBe	NULL
is	NULL
deficient	NULL
in	NULL
1.3E2	NULL
.	NULL

1.3E2	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
a	NULL
mutant	NULL
with	NULL
a	NULL
redox	NULL
defect	NULL
.	NULL

Since	NULL
all	NULL
the	NULL
stimuli	NULL
that	NULL
do	NULL
not	NULL
activate	NULL
NF-kB	NULL
in	NULL
1.3E2	NULL
use	NULL
a	NULL
redox-regulated	NULL
pathway	NULL
,	NULL
we	NULL
wondered	NULL
whether	NULL
the	NULL
oxidative	NULL
state	NULL
of	NULL
1.3E2	NULL
,	NULL
before	NULL
or	NULL
after	NULL
stimulation	NULL
,	NULL
could	NULL
be	NULL
perturbed	NULL
.	NULL

A	NULL
FACS	NULL
protocol	NULL
,	NULL
which	NULL
measures	NULL
the	NULL
level	NULL
of	NULL
cytoplasmic	NULL
ROIs	NULL
with	NULL
the	NULL
DCFH	NULL
dye	NULL
,	NULL
was	NULL
used	NULL
.	NULL

Surprisingly	NULL
,	NULL
under	NULL
standard	NULL
culture	NULL
conditions	NULL
(	NULL
10	NULL
%	NULL
FCS-RPMI	NULL
)	NULL
,	NULL
70	NULL
%	NULL
,	NULL
/3	NULL
cells	NULL
exhibited	NULL
a	NULL
high	NULL
ROI	NULL
level	NULL
(	NULL
Fig	NULL
.	NULL

9A	NULL
)	NULL
and	NULL
this	NULL
level	NULL
was	NULL
only	NULL
weakly	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
A	NULL
702/3	NULL
1.3E2	NULL
20000	NULL
7	NULL
2	NULL
'	NULL
C	NULL
D	NULL
o	NULL
€	NULL
E	NULL
10000	NULL
7	NULL
0	NULL
3	NULL
-A	NULL
C	NULL
OL	NULL
P	NULL
1	NULL
R	NULL
C	NULL
OL	NULL
P	NULL
I	NULL
R	NULL
NF-	NULL
«	NULL
B	NULL
ACTIVATION-DEFICIENT	NULL
CELL	NULL
LINE	NULL
|	NULL
1445	NULL
B	NULL
8000	NULL
-	NULL
70273	NULL
1.3E2	NULL
&	NULL
80094	NULL
°C	NULL
D	NULL
©	NULL
&	NULL
40007	NULL
$	NULL
o	NULL
3	NULL
-	NULL
!	NULL

2000	NULL
{	NULL
O-C	NULL
T	NULL
C	NULL
T	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Defective	NULL
NF-kB	NULL
transcriptional	NULL
activity	NULL
in	NULL
1.3E2	NULL
.	NULL

wt	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
an	NULL
Igx-Luc	NULL
reporter	NULL
plasmid	NULL
and	NULL
stimulated	NULL
24	NULL
h	NULL
later	NULL
with	NULL
15	NULL
jg	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
(	NULL
L	NULL
)	NULL
,	NULL
100	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
(	NULL
P	NULL
)	NULL
,	NULL
20	NULL
ng	NULL
of	NULL
IL-1	NULL
per	NULL
ml	NULL
(	NULL
I	NULL
)	NULL
,	NULL
or	NULL
0.1	NULL
mg	NULL
of	NULL
poly	NULL
(	NULL
I-C	NULL
)	NULL
per	NULL
ml	NULL
(	NULL
R	NULL
)	NULL
for	NULL
6	NULL
h.	NULL
Cellular	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
the	NULL
luciferase	NULL
activity	NULL
was	NULL
compared	NULL
to	NULL
that	NULL
of	NULL
nonstimulated	NULL
cells	NULL
(	NULL
C	NULL
)	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
.	NULL

For	NULL
each	NULL
stimulus	NULL
at	NULL
least	NULL
four	NULL
experiments	NULL
,	NULL
in	NULL
duplicate	NULL
,	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
HTLV-1-derived	NULL
Tax	NULL
frans-activator	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
1.3E2	NULL
.	NULL

wt	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
an	NULL
Igx-Luc	NULL
reporter	NULL
plasmid	NULL
,	NULL
together	NULL
with	NULL
either	NULL
an	NULL
empty	NULL
expression	NULL
vector	NULL
(	NULL
C	NULL
)	NULL
or	NULL
a	NULL
vector	NULL
expressing	NULL
Tax	NULL
(	NULL
T	NULL
)	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
of	NULL
cellular	NULL
extracts	NULL
was	NULL
determined	NULL
24	NULL
h	NULL
later	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
.	NULL

Three	NULL
other	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
duplicate	NULL
and	NULL
gave	NULL
similar	NULL
results	NULL
.	NULL

modified	NULL
by	NULL
H	NULL
,	NULL
O	NULL
,	NULL
whereas	NULL
it	NULL
remained	NULL
unaffected	NULL
by	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
observation	NULL
was	NULL
made	NULL
with	NULL
1.3E2	NULL
cells	NULL
,	NULL
excluding	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
basal	NULL
redox	NULL
state	NULL
of	NULL
the	NULL
mutant	NULL
cell	NULL
was	NULL
perturbed	NULL
.	NULL

To	NULL
analyze	NULL
a	NULL
putative	NULL
production	NULL
of	NULL
ROIs	NULL
during	NULL
the	NULL
stimulation	NULL
process	NULL
,	NULL
we	NULL
tried	NULL
to	NULL
grow	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
cells	NULL
in	NULL
2	NULL
%	NULL
FCS-RPML	NULL
.	NULL

This	NULL
treatment	NULL
resulted	NULL
in	NULL
a	NULL
large	NULL
drop	NULL
in	NULL
the	NULL
internal	NULL
ROI	NULL
level	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
,	NULL
compare	NULL
bars	NULL
1	NULL
and	NULL
6	NULL
to	NULL
bars	NULL
3	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
this	NULL
ROI	NULL
level	NULL
could	NULL
not	NULL
be	NULL
substantially	NULL
modified	NULL
by	NULL
PMA	NULL
or	NULL
IL-1	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
9	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
whereas	NULL
it	NULL
could	NULL
be	NULL
strongly	NULL
increased	NULL
by	NULL
500	NULL
uM	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
10	NULL
)	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
a	NULL
level	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
with	NULL
cells	NULL
grown	NULL
at	NULL
high	NULL
serum	NULL
concentrations	NULL
was	NULL
obtained	NULL
.	NULL

Such	NULL
an	NULL
observation	NULL
allowed	NULL
us	NULL
to	NULL
investigate	NULL
whether	NULL
an	NULL
oxidative	NULL
stress	NULL
was	NULL
able	NULL
by	NULL
itself	NULL
to	NULL
activate	NULL
NF-kB	NULL
in	NULL
70Z/3	NULL
or	NULL
to	NULL
correct	NULL
the	NULL
defect	NULL
of	NULL
1.3E2	NULL
,	NULL
by	NULL
preincubating	NULL
the	NULL
cells	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
before	NULL
adding	NULL
LPS	NULL
.	NULL

In	NULL
neither	NULL
case	NULL
were	NULL
we	NULL
able	NULL
to	NULL
detect	NULL
any	NULL
induced	NULL
NF-kB	NULL
binding	NULL
activity	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
EMSA	NULL
,	NULL
or	NULL
induced	NULL
transcriptional	NULL
activity	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
a	NULL
luciferase	NULL
assay	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
,	NULL
therefore	NULL
,	NULL
did	NULL
not	NULL
reveal	NULL
any	NULL
redox	NULL
perturbation	NULL
in	NULL
1.3E2	NULL
.	NULL

They	NULL
also	NULL
indicated	NULL
that	NULL
a	NULL
redox	NULL
stress	NULL
was	NULL
unable	NULL
by	NULL
itself	NULL
to	NULL
induce	NULL
NF-KB	NULL
.	NULL

Several	NULL
other	NULL
signaling	NULL
cascades	NULL
are	NULL
active	NULL
in	NULL
1.3E2	NULL
.	NULL

Under	NULL
standard	NULL
growth	NULL
conditions	NULL
,	NULL
the	NULL
growth	NULL
rate	NULL
of	NULL
1.3E2	NULL
is	NULL
slightly	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
wt	NULL
70Z/3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
basal	NULL
metabolism	NULL
of	NULL
this	NULL
cell	NULL
line	NULL
is	NULL
not	NULL
perturbed	NULL
.	NULL

To	NULL
confirm	NULL
this	NULL
view	NULL
,	NULL
we	NULL
analyzed	NULL
various	NULL
transduction	NULL
cascades	NULL
involving	NULL
kinases	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
family	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
12	NULL
,	NULL
25	NULL
,	NULL
and	NULL
58	NULL
)	NULL
.	NULL

Two	NULL
distinct	NULL
sets	NULL
of	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

In	NULL
the	NULL
first	NULL
set	NULL
,	NULL
the	NULL
signal-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
ERK2	NULL
and	NULL
p38	NULL
was	NULL
ana-lyzed	NULL
.	NULL

In	NULL
70Z/3	NULL
,	NULL
ERK2	NULL
and	NULL
p38	NULL
can	NULL
be	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
and	NULL
sorbitol	NULL
,	NULL
respectively	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
therefore	NULL
prepared	NULL
from	NULL
stimulated	NULL
wt	NULL
70Z	NULL
,	NULL
/3	NULL
and	NULL
1.3E2	NULL
cells	NULL
,	NULL
run	NULL
on	NULL
a	NULL
denaturing	NULL
gel	NULL
and	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
the	NULL
antiphosphotyrosine	NULL
antibody	NULL
4G10	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

10	NULL
,	NULL
ERK2	NULL
and	NULL
p38	NULL
were	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
in	NULL
wt	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
.	NULL

The	NULL
second	NULL
set	NULL
of	NULL
experiments	NULL
used	NULL
transfection	NULL
of	NULL
wt	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
cells	NULL
with	NULL
reporter	NULL
plasmids	NULL
carrying	NULL
multicopies	NULL
of	NULL
the	NULL
tetradecanoyl	NULL
phorbol	NULL
acetate	NULL
(	NULL
TPA	NULL
)	NULL
-responsive	NULL
element	NULL
(	NULL
TRE	NULL
)	NULL
or	NULL
serum	NULL
responsive	NULL
element	NULL
(	NULL
SRE	NULL
)	NULL
.	NULL

AP-1	NULL
,	NULL
the	NULL
transcription	NULL
factor	NULL
that	NULL
recognizes	NULL
TRE	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
respond	NULL
to	NULL
JNK	NULL
activation	NULL
(	NULL
12	NULL
,	NULL
25	NULL
,	NULL
58	NULL
)	NULL
whereas	NULL
TCF	NULL
and	NULL
SRF	NULL
,	NULL
the	NULL
SRE-binding	NULL
proteins	NULL
,	NULL
can	NULL
be	NULL
targets	NULL
of	NULL
ERK	NULL
,	NULL
p38	NULL
,	NULL
or	NULL
JNK	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
stimulus	NULL
tested	NULL
.	NULL

Despite	NULL
repeated	NULL
attempts	NULL
,	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
observe	NULL
any	NULL
substantial	NULL
activation	NULL
of	NULL
the	NULL
TRE-Luc	NULL
plasmid	NULL
by	NULL
PMA	NULL
in	NULL
wt	NULL
precluding	NULL
a	NULL
comparison	NULL
with	NULL
1.3E2	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
an	NULL
SRE-Lue	NULL
plasmid	NULL
was	NULL
responsive	NULL
to	NULL
PMA	NULL
or	NULL
sorbitol	NULL
to	NULL
similar	NULL
extents	NULL
in	NULL
wt	NULL
70Z	NULL
%	NULL
/3	NULL
and	NULL
1.3E2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
at	NULL
least	NULL
two	NULL
different	NULL
MAPK	NULL
pathways	NULL
were	NULL
fully	NULL
functional	NULL
in	NULL
1.3E2	NULL
.	NULL

DISCUSSION	NULL
A	NULL
hallmark	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
its	NULL
remarkable	NULL
capacity	NULL
to	NULL
respond	NULL
to	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
stimuli	NULL
.	NULL

Only	NULL
recently	NULL
has	NULL
it	NULL
been	NULL
shown	NULL
that	NULL
all	NULL
these	NULL
stimuli	NULL
act	NULL
by	NULL
inactivating	NULL
IxB	NULL
molecules	NULL
.	NULL

In	NULL
the	NULL
case	NULL
A	NULL
C	NULL
L	NULL
-	NULL
OT	NULL
4	NULL
Cal	NULL
_C	NULL
sures	NULL
comes	NULL
-	NULL
Drm	NULL
mop	NULL
rattan	NULL
-/	NULL
HEKCEC	NULL
(	NULL
2	NULL
2313	NULL
in	NULL
Swe	NULL
B	NULL
C	NULL
L	NULL
T	NULL
P	NULL
1	NULL
Cal	NULL
.	NULL

-o	NULL
BR	NULL
-	NULL
oF	NULL
-	NULL
o	NULL
$	NULL
-	NULL
$	NULL
-	NULL
$	NULL
o	NULL
o-	NULL
4+	NULL
(	NULL
PDTC	NULL
)	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

The	NULL
stimuli	NULL
that	NULL
do	NULL
not	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
1.3E2	NULL
act	NULL
on	NULL
Ser	NULL
32/36	NULL
of	NULL
IxBa	NULL
and	NULL
use	NULL
a	NULL
PDTC-sensitive	NULL
pathway	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Role	NULL
of	NULL
Ser	NULL
32/36	NULL
in	NULL
the	NULL
degradation	NULL
process	NULL
.	NULL

70Z	NULL
,	NULL
/3	NULL
cells	NULL
expressing	NULL
a	NULL
doubly	NULL
mutated	NULL
(	NULL
Ser	NULL
32/36	NULL
-	NULL
>	NULL
Ala	NULL
32/36	NULL
)	NULL
hIxBa	NULL
molecule	NULL
were	NULL
mock	NULL
stimulated	NULL
(	NULL
lanes	NULL
C	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
(	NULL
lane	NULL
L	NULL
)	NULL
,	NULL
50	NULL
M	NULL
Taxol	NULL
(	NULL
lane	NULL
T	NULL
)	NULL
,	NULL
20	NULL
ng	NULL
of	NULL
IL-1	NULL
per	NULL
ml	NULL
(	NULL
lane	NULL
I	NULL
)	NULL
,	NULL
or	NULL
300	NULL
nM	NULL
calyculin	NULL
A	NULL
(	NULL
lane	NULL
Cal	NULL
.	NULL
)	NULL

for	NULL
1	NULL
h.	NULL
Degradation	NULL
of	NULL
hIxBa	NULL
was	NULL
monitored	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

The	NULL
relative	NULL
migrations	NULL
of	NULL
exogenous	NULL
hIxBa	NULL
and	NULL
endogenous	NULL
mIxBa	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
right	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Effect	NULL
of	NULL
the	NULL
antioxidant	NULL
PDTC	NULL
on	NULL
IxBa	NULL
«	NULL
degradation	NULL
.	NULL

wt	NULL
70Z/3	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
100	NULL
wM	NULL
PDTC	NULL
for	NULL
45	NULL
min	NULL
and	NULL
then	NULL
left	NULL
untreated	NULL
(	NULL
lane	NULL
C	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
for	NULL
40	NULL
min	NULL
(	NULL
lane	NULL
L	NULL
)	NULL
,	NULL
50	NULL
M	NULL
Taxol	NULL
for	NULL
30	NULL
min	NULL
(	NULL
lane	NULL
T	NULL
)	NULL
,	NULL
100	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
for	NULL
20	NULL
min	NULL
(	NULL
lane	NULL
P	NULL
)	NULL
,	NULL
20	NULL
ng	NULL
of	NULL
IL-1	NULL
per	NULL
ml	NULL
for	NULL
30	NULL
min	NULL
(	NULL
Jane	NULL
1	NULL
)	NULL
,	NULL
or	NULL
300	NULL
nM	NULL
calyculin	NULL
A	NULL
for	NULL
20	NULL
min	NULL
(	NULL
lane	NULL
Cal	NULL
)	NULL
.	NULL

IxBa	NULL
levels	NULL
were	NULL
monitored	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

1446	NULL
COURTOIS	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
702/3	NULL
1.3E2	NULL
LPS	NULL
|	NULL
smemmm	NULL
an	NULL
.	NULL

I	NULL
«	NULL
onne	NULL
nme	NULL
atis	NULL
Taxol	NULL
*	NULL
«	NULL
Aime	NULL
cities	NULL
oem	NULL
O	NULL
30	NULL
60	NULL
90	NULL
0	NULL
30	NULL
60	NULL
90	NULL
(	NULL
mn	NULL
)	NULL
CAl	NULL
.	NULL

|	NULL
summ	NULL
--	NULL
-	NULL
»	NULL
--	NULL
capers	NULL
coney	NULL
«	NULL
ani	NULL
0	NULL
20	NULL
40	NULL
60	NULL
0	NULL
20	NULL
40	NULL
60	NULL
(	NULL
mn	NULL
)	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

B	NULL
Z	NULL
Ze	NULL
Zs	NULL
Es	NULL
Es	NULL
E	NULL
--	NULL
-	NULL
“	NULL
._1§	NULL
;	NULL
atts	NULL
s	NULL
-he	NULL
=o	NULL
-	NULL
o	NULL
$	NULL
o-	NULL
o	NULL
$	NULL
-	NULL
(	NULL
LPS	NULL
)	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Degradation	NULL
of	NULL
IxBB	NULL
and	NULL
I	NULL
«	NULL
Be	NULL
is	NULL
defective	NULL
in	NULL
1.3E2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
IBB	NULL
levels	NULL
in	NULL
wt	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
following	NULL
exposure	NULL
to	NULL
15	NULL
ug	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
,	NULL
100	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
,	NULL
50	NULL
M	NULL
Taxol	NULL
,	NULL
or	NULL
300	NULL
nM	NULL
calyculin	NULL
A	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
myc-hIxBge	NULL
levels	NULL
in	NULL
wt	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
.	NULL

wt	NULL
70Z/3	NULL
(	NULL
lane	NULL
Z	NULL
)	NULL
,	NULL
1.3E2	NULL
(	NULL
lane	NULL
E	NULL
)	NULL
,	NULL
and	NULL
cells	NULL
stably	NULL
expressing	NULL
myc-hI	NULL
«	NULL
Be	NULL
(	NULL
lanes	NULL
Ze	NULL
and	NULL
Eg	NULL
)	NULL
were	NULL
pre-incubated	NULL
for	NULL
45	NULL
min	NULL
with	NULL
10	NULL
jg	NULL
of	NULL
cycloheximide	NULL
per	NULL
ml	NULL
and	NULL
then	NULL
stimulated	NULL
for	NULL
90	NULL
min	NULL
with	NULL
15	NULL
pg	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-€	NULL
antibody	NULL
(	NULL
no	NULL
.	NULL

812	NULL
)	NULL
and	NULL
analyzed	NULL
with	NULL
an	NULL
anti-myc	NULL
antibody	NULL
.	NULL

Ig	NULL
,	NULL
heavy	NULL
chain	NULL
of	NULL
immunoglobulin	NULL
G.	NULL
of	NULL
IxBa	NULL
,	NULL
for	NULL
most	NULL
stimuli	NULL
,	NULL
inactivation	NULL
proceeds	NULL
according	NULL
to	NULL
the	NULL
following	NULL
sequence	NULL
.	NULL

First	NULL
,	NULL
a	NULL
phosphorylation	NULL
event	NULL
takes	NULL
place	NULL
on	NULL
Ser	NULL
32/36	NULL
,	NULL
and	NULL
then	NULL
the	NULL
molecule	NULL
is	NULL
ubiquitinated	NULL
on	NULL
Lys	NULL
21/22	NULL
and	NULL
subsequently	NULL
degraded	NULL
by	NULL
the	NULL
268	NULL
proteasome	NULL
.	NULL

It	NULL
is	NULL
still	NULL
not	NULL
known	NULL
whether	NULL
Ser	NULL
32/36	NULL
phosphorylation	NULL
results	NULL
from	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
kinase	NULL
or	NULL
from	NULL
the	NULL
inactivation	NULL
of	NULL
a	NULL
phosphatase	NULL
.	NULL

It	NULL
also	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
whether	NULL
one	NULL
or	NULL
several	NULL
distinct	NULL
kinases	NULL
(	NULL
or	NULL
phosphatases	NULL
)	NULL
participate	NULL
in	NULL
the	NULL
IxBa	NULL
phosphorylation	NULL
process	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
mutant	NULL
cell	NULL
line	NULL
1.3E2	NULL
does	NULL
not	NULL
degrade	NULL
IxBa	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
,	NULL
Taxol	NULL
,	NULL
PMA	NULL
,	NULL
IL-1	NULL
,	NULL
or	NULL
dsRNA	NULL
.	NULL

More	NULL
specifically	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
an	NULL
absence	NULL
of	NULL
phosphorylation	NULL
on	NULL
Ser	NULL
32/36	NULL
after	NULL
stimulation	NULL
with	NULL
these	NULL
agents	NULL
.	NULL

Since	NULL
neither	NULL
IxBa	NULL
,	NULL
p50	NULL
,	NULL
nor	NULL
relA	NULL
appears	NULL
to	NULL
be	NULL
mutated	NULL
,	NULL
the	NULL
1.3E2	NULL
cell	NULL
line	NULL
represents	NULL
a	NULL
transduction	NULL
mutant	NULL
that	NULL
is	NULL
defective	NULL
in	NULL
a	NULL
step	NULL
shared	NULL
by	NULL
at	NULL
least	NULL
five	NULL
different	NULL
stimuli	NULL
.	NULL

If	NULL
a	NULL
single	NULL
kinase	NULL
is	NULL
responsible	NULL
for	NULL
Ser	NULL
32/36-induced	NULL
phosphorylation	NULL
,	NULL
such	NULL
a	NULL
kinase	NULL
could	NULL
be	NULL
mutated	NULL
in	NULL
1.3E2	NULL
.	NULL

Alternatively	NULL
,	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
inactivation	NULL
of	NULL
a	NULL
phosphatase	NULL
,	NULL
the	NULL
inactivation	NULL
step	NULL
could	NULL
be	NULL
defective	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
more	NULL
upstream	NULL
component	NULL
could	NULL
be	NULL
mutated	NULL
but	NULL
it	NULL
would	NULL
have	NULL
to	NULL
be	NULL
1200	NULL
7	NULL
702/73	NULL
1.3E2	NULL
1000	NULL
1	NULL
800	NULL
1	NULL
600	NULL
4007	NULL
2001	NULL
o	NULL
M	NULL
me	NULL
o	NULL
5	NULL
10	NULL
a	NULL
5	NULL
Emission	NULL
at	NULL
525nm	NULL
(	NULL
Relative	NULL
Units	NULL
)	NULL
1G	NULL
(	NULL
mn	NULL
)	NULL
common	NULL
to	NULL
all	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
which	NULL
are	NULL
inactive	NULL
in	NULL
inducing	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
1.3EZ	NULL
.	NULL

The	NULL
little	NULL
we	NULL
know	NULL
about	NULL
the	NULL
signaling	NULL
pathways	NULL
that	NULL
are	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
,	NULL
Taxol	NULL
,	NULL
PMA	NULL
,	NULL
IL-1	NULL
,	NULL
or	NULL
dsRNA	NULL
does	NULL
not	NULL
provide	NULL
any	NULL
obvious	NULL
common	NULL
intermediate	NULL
.	NULL

Nevertheless	NULL
,	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
the	NULL
five	NULL
stimuli	NULL
listed	NULL
above	NULL
is	NULL
inhibited	NULL
by	NULL
preincubating	NULL
the	NULL
cells	NULL
with	NULL
the	NULL
antioxidant	NULL
PDTC	NULL
,	NULL
indicating	NULL
the	NULL
requirement	NULL
of	NULL
a	NULL
redox-regulated	NULL
step	NULL
.	NULL

Two	NULL
models	NULL
have	NULL
been	NULL
proposed	NULL
to	NULL
explain	NULL
the	NULL
effect	NULL
of	NULL
antioxidants	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

In	NULL
the	NULL
first	NULL
,	NULL
the	NULL
stimuli	NULL
that	NULL
activate	NULL
NF-kB	NULL
are	NULL
able	NULL
to	NULL
generate	NULL
ROIs	NULL
,	NULL
and	NULL
these	NULL
ROIs	NULL
,	NULL
acting	NULL
as	NULL
second	NULL
messengers	NULL
,	NULL
modulate	NULL
the	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
(	NULL
47-49	NULL
)	NULL
.	NULL

Antioxidants	NULL
are	NULL
believed	NULL
to	NULL
act	NULL
by	NULL
neutralizing	NULL
such	NULL
intermediates	NULL
.	NULL

If	NULL
this	NULL
model	NULL
is	NULL
correct	NULL
,	NULL
a	NULL
possibility	NULL
would	NULL
be	NULL
that	NULL
LPS	NULL
,	NULL
PMA	NULL
,	NULL
IL-1	NULL
,	NULL
etc	NULL
.	NULL

,	NULL
act	NULL
on	NULL
the	NULL
same	NULL
molecule	NULL
to	NULL
generate	NULL
an	NULL
ROI	NULL
and	NULL
that	NULL
this	NULL
molecule	NULL
is	NULL
inactive	NULL
in	NULL
1.3E2	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
it	NULL
should	NULL
be	NULL
possible	NULL
to	NULL
recover	NULL
NF-kB	NULL
activation	NULL
in	NULL
1.3E2	NULL
by	NULL
artificially	NULL
raising	NULL
the	NULL
ROI	NULL
level	NULL
.	NULL

Unfortunately	NULL
,	NULL
despite	NULL
our	NULL
repeated	NULL
attempts	NULL
,	NULL
such	NULL
recovery	NULL
was	NULL
not	NULL
observed	NULL
by	NULL
treating	NULL
cells	NULL
with	NULL
H	NULL
,	NULL
O	NULL
,	NULL
In	NULL
the	NULL
second	NULL
model	NULL
proposed	NULL
to	NULL
explain	NULL
the	NULL
effect	NULL
of	NULL
anti	NULL
B	NULL
2000	NULL
7	NULL
2	NULL
5	NULL
7023	NULL
1.322	NULL
0	NULL
.2	NULL
3	NULL
0	NULL
&	NULL
E	NULL
10007	NULL
to	NULL
)	NULL
&	NULL
c	NULL
0	NULL
E	NULL
E	NULL
tJ	NULL
O—	NULL
1	NULL
20	NULL
30	NULL
4	NULL
S5	NULL
60	NULL
7	NULL
8	NULL
9	NULL
19	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

Analysis	NULL
of	NULL
ROI	NULL
levels	NULL
in	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Kinetics	NULL
of	NULL
DCFH	NULL
fluorescence	NULL
.	NULL

70Z/3	NULL
and	NULL
1.3E2	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
with	NULL
5	NULL
pM	NULL
DCFH	NULL
at	NULL
37°C	NULL
and	NULL
then	NULL
analyzed	NULL
by	NULL
FACS	NULL
.	NULL

Three	NULL
experiments	NULL
were	NULL
performed	NULL
,	NULL
and	NULL
the	NULL
results	NULL
of	NULL
a	NULL
representative	NULL
experiment	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Effect	NULL
of	NULL
growth	NULL
conditions	NULL
and	NULL
stimulation	NULL
on	NULL
the	NULL
ROI	NULL
levels	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
in	NULL
10	NULL
%	NULL
FCS-RPMI	NULL
(	NULL
bars	NULL
1	NULL
,	NULL
2	NULL
,	NULL
6	NULL
,	NULL
and	NULL
7	NULL
)	NULL
or	NULL
2	NULL
%	NULL
FCS-RPMI	NULL
(	NULL
bars	NULL
3	NULL
to	NULL
5	NULL
,	NULL
and	NULL
8	NULL
to	NULL
10	NULL
)	NULL
and	NULL
stimulated	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
(	NULL
bars	NULL
4	NULL
and	NULL
9	NULL
)	NULL
or	NULL
500	NULL
aM	NULL
H	NULL
,	NULL
O	NULL
,	NULL
(	NULL
bars	NULL
5	NULL
and	NULL
10	NULL
)	NULL
for	NULL
30	NULL
min	NULL
.	NULL

After	NULL
a	NULL
5-min	NULL
incubation	NULL
at	NULL
37°C	NULL
with	NULL
5	NULL
wM	NULL
DCFH	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
FACS	NULL
.	NULL

Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
A	NULL
70Z2/3	NULL
1.3E2	NULL
¢	NULL
s	NULL
S	NULL
w'zm	NULL
ERK2	NULL
m	NULL
zs	NULL
``	NULL
-~	NULL
p38	NULL
1.362	NULL
S000	NULL
Tozs	NULL
1.322	NULL
6000	NULL
70273	NULL
4000	NULL
Luciferase	NULL
units	NULL
2000	NULL
0	NULL
CP	NULL
COP	NULL
C	NULL
Ss	NULL
C	NULL
S	NULL
FIG	NULL
.	NULL

10	NULL
.	NULL

MAPK	NULL
activation	NULL
pathways	NULL
are	NULL
functional	NULL
in	NULL
1.3E2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
ERK	NULL
2	NULL
and	NULL
p38	NULL
in	NULL
response	NULL
to	NULL
a	NULL
15-min	NULL
exposure	NULL
to	NULL
100	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
(	NULL
lanes	NULL
P	NULL
)	NULL
or	NULL
0.4	NULL
M	NULL
sorbitol	NULL
(	NULL
lanes	NULL
S	NULL
)	NULL
.	NULL

Lanes	NULL
C	NULL
contain	NULL
mock-stimulated	NULL
cells	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
were	NULL
run	NULL
on	NULL
a	NULL
10	NULL
%	NULL
acrylamide	NULL
gel	NULL
and	NULL
analyzed	NULL
after	NULL
Western	NULL
blotting	NULL
with	NULL
the	NULL
4G10	NULL
antibody	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transcriptional	NULL
activation	NULL
of	NULL
the	NULL
reporter	NULL
construct	NULL
SRE-Luc	NULL
.	NULL

SRE-Luc	NULL
was	NULL
transiently	NULL
transfected	NULL
into	NULL
wt	NULL
70Z/3	NULL
or	NULL
1.3E2	NULL
and	NULL
then	NULL
mock	NULL
stimulated	NULL
(	NULL
bars	NULL
C	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
(	NULL
bars	NULL
P	NULL
)	NULL
or	NULL
0.4	NULL
M	NULL
sorbitol	NULL
(	NULL
bars	NULL
S	NULL
)	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
repeated	NULL
twice	NULL
,	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

oxidants	NULL
on	NULL
NF-kB	NULL
activation	NULL
,	NULL
some	NULL
undefined	NULL
step	NULL
in	NULL
the	NULL
transduction	NULL
pathway	NULL
that	NULL
leads	NULL
to	NULL
IxBa	NULL
degradation	NULL
is	NULL
thought	NULL
to	NULL
depend	NULL
on	NULL
the	NULL
redox	NULL
state	NULL
of	NULL
the	NULL
cytoplasm	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
antioxidants	NULL
would	NULL
act	NULL
by	NULL
globally	NULL
modifying	NULL
the	NULL
redox	NULL
state	NULL
of	NULL
the	NULL
cell	NULL
.	NULL

As	NULL
presented	NULL
above	NULL
,	NULL
we	NULL
have	NULL
not	NULL
been	NULL
able	NULL
to	NULL
detect	NULL
any	NULL
significant	NULL
difference	NULL
between	NULL
the	NULL
redox	NULL
states	NULL
of	NULL
wt	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
.	NULL

We	NULL
have	NULL
observed	NULL
that	NULL
under	NULL
standard	NULL
growth	NULL
conditions	NULL
,	NULL
both	NULL
wt	NULL
70Z/3	NULL
and	NULL
1.3E2	NULL
exhibit	NULL
the	NULL
same	NULL
high	NULL
ROI	NULL
level	NULL
.	NULL

All	NULL
these	NULL
observations	NULL
,	NULL
therefore	NULL
,	NULL
do	NULL
not	NULL
favor	NULL
the	NULL
view	NULL
that	NULL
1.3E2	NULL
is	NULL
a	NULL
redox-deficient	NULL
mutant	NULL
.	NULL

Another	NULL
important	NULL
feature	NULL
of	NULL
1.3E2	NULL
is	NULL
the	NULL
absence	NULL
of	NULL
IxBB	NULL
and	NULL
IxBg	NULL
degradation	NULL
in	NULL
response	NULL
to	NULL
stimuli	NULL
like	NULL
LPS	NULL
,	NULL
PMA	NULL
,	NULL
IL-1	NULL
,	NULL
or	NULL
Taxol	NULL
.	NULL

This	NULL
suggests	NULL
some	NULL
common	NULL
requirement	NULL
for	NULL
the	NULL
degradation	NULL
of	NULL
the	NULL
three	NULL
major	NULL
NF-KB	NULL
inhibitors	NULL
.	NULL

Although	NULL
numerous	NULL
questions	NULL
remain	NULL
as	NULL
to	NULL
how	NULL
the	NULL
IxBB	NULL
and	NULL
IxBe	NULL
inhibitors	NULL
are	NULL
inactivated	NULL
,	NULL
four	NULL
facts	NULL
are	NULL
worth	NULL
noting	NULL
.	NULL

First	NULL
,	NULL
degradation	NULL
of	NULL
the	NULL
three	NULL
inhibitors	NULL
,	NULL
in	NULL
response	NULL
to	NULL
the	NULL
stimuli	NULL
listed	NULL
above	NULL
,	NULL
is	NULL
PDTC	NULL
sensitive	NULL
.	NULL

Second	NULL
,	NULL
in	NULL
each	NULL
case	NULL
,	NULL
proteolysis	NULL
is	NULL
carried	NULL
out	NULL
by	NULL
the	NULL
proteasome	NULL
complex	NULL
.	NULL

Third	NULL
,	NULL
IxBB	NULL
and	NULL
IxBg	NULL
exhibit	NULL
a	NULL
two-serine	NULL
motif	NULL
(	NULL
Ser	NULL
19	NULL
and	NULL
23	NULL
for	NULL
B	NULL
;	NULL
Ser	NULL
157	NULL
and	NULL
161	NULL
for	NULL
£	NULL
)	NULL
very	NULL
similar	NULL
to	NULL
the	NULL
one	NULL
containing	NULL
Ser	NULL
32	NULL
and	NULL
36	NULL
in	NULL
IxBa	NULL
.	NULL

Mutagenesis	NULL
of	NULL
both	NULL
serines	NULL
in	NULL
this	NULL
motif	NULL
inhibits	NULL
IxBB	NULL
and	NULL
IxBg	NULL
degradation	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
(	NULL
16	NULL
,	NULL
59a	NULL
,	NULL
61	NULL
)	NULL
.	NULL

Fourth	NULL
,	NULL
in	NULL
our	NULL
cell	NULL
system	NULL
,	NULL
IxBa	NULL
,	NULL
IxBB	NULL
,	NULL
and	NULL
IxBg	NULL
appear	NULL
to	NULL
respond	NULL
to	NULL
the	NULL
same	NULL
set	NULL
of	NULL
stimuli	NULL
(	NULL
Results	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
although	NULL
some	NULL
quantitative	NULL
differences	NULL
can	NULL
be	NULL
noted	NULL
.	NULL

All	NULL
these	NULL
observations	NULL
point	NULL
to	NULL
a	NULL
similar	NULL
mode	NULL
of	NULL
degradation	NULL
for	NULL
the	NULL
three	NULL
inhibitors	NULL
.	NULL

Since	NULL
we	NULL
already	NULL
know	NULL
,	NULL
from	NULL
the	NULL
IxBa	NULL
analysis	NULL
,	NULL
that	NULL
proteolysis	NULL
by	NULL
the	NULL
proteasome	NULL
is	NULL
not	NULL
defective	NULL
in	NULL
1.3E2	NULL
but	NULL
induced	NULL
phosphorylation	NULL
is	NULL
abolished	NULL
,	NULL
a	NULL
similar	NULL
NF-kB	NULL
ACTIVATION-DEFICIENT	NULL
CELL	NULL
LINE	NULL
-	NULL
1447	NULL
problem	NULL
may	NULL
affect	NULL
IxBB	NULL
and	NULL
IxBg	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
IxBB	NULL
and	NULL
could	NULL
be	NULL
the	NULL
targets	NULL
of	NULL
the	NULL
same	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
[	NULL
or	NULL
phosphatase	NULL
(	NULL
s	NULL
)	NULL
]	NULL
as	NULL
IxBao	NULL
.	NULL

Alternatively	NULL
,	NULL
different	NULL
kinases	NULL
(	NULL
or	NULL
phosphatases	NULL
)	NULL
could	NULL
be	NULL
recruited	NULL
but	NULL
their	NULL
activation	NULL
would	NULL
be	NULL
under	NULL
the	NULL
same	NULL
control	NULL
.	NULL

In	NULL
any	NULL
case	NULL
,	NULL
1.3E2	NULL
analysis	NULL
reveals	NULL
an	NULL
unexpected	NULL
functional	NULL
coupling	NULL
between	NULL
IxBa	NULL
,	NULL
IxBB	NULL
,	NULL
and	NULL
IxBg	NULL
inactivation	NULL
.	NULL

Three	NULL
kinds	NULL
of	NULL
stimuli	NULL
,	NULL
the	NULL
osmotic	NULL
shock	NULL
,	NULL
the	NULL
phosphatase	NULL
inhibitors	NULL
,	NULL
and	NULL
the	NULL
viral	NULL
transactivator	NULL
Tax	NULL
,	NULL
are	NULL
still	NULL
able	NULL
to	NULL
activate	NULL
NF-kB	NULL
in	NULL
1.3EZ	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
degradation	NULL
of	NULL
IxBa	NULL
in	NULL
response	NULL
to	NULL
osmotic	NULL
shock	NULL
does	NULL
not	NULL
require	NULL
Ser	NULL
32	NULL
and	NULL
36	NULL
(	NULL
14	NULL
)	NULL
,	NULL
suggesting	NULL
an	NULL
alternative	NULL
mode	NULL
of	NULL
NF-kB	NULL
activation	NULL
that	NULL
is	NULL
still	NULL
functional	NULL
in	NULL
1.3E2	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
calyculin	NULL
A	NULL
and	NULL
okadaic	NULL
acid	NULL
,	NULL
the	NULL
two	NULL
phosphatase	NULL
inhibitors	NULL
we	NULL
have	NULL
used	NULL
,	NULL
our	NULL
results	NULL
were	NULL
more	NULL
surprising	NULL
.	NULL

We	NULL
have	NULL
indeed	NULL
shown	NULL
that	NULL
IxBa	NULL
degradation	NULL
by	NULL
both	NULL
inhibitors	NULL
requires	NULL
Ser	NULL
32	NULL
and	NULL
36	NULL
and	NULL
is	NULL
proteasome	NULL
dependent	NULL
but	NULL
is	NULL
not	NULL
sensitive	NULL
to	NULL
PDTC	NULL
.	NULL

How	NULL
can	NULL
we	NULL
reconcile	NULL
this	NULL
observation	NULL
with	NULL
the	NULL
data	NULL
reported	NULL
above	NULL
?	NULL

It	NULL
could	NULL
indicate	NULL
that	NULL
the	NULL
phosphatase	NULL
inhibitors	NULL
are	NULL
able	NULL
to	NULL
indirectly	NULL
activate	NULL
the	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
or	NULL
to	NULL
directly	NULL
inhibit	NULL
the	NULL
phos-phatase	NULL
(	NULL
s	NULL
)	NULL
involved	NULL
in	NULL
IxBa	NULL
degradation	NULL
without	NULL
using	NULL
the	NULL
PDTC-sensitive	NULL
step	NULL
.	NULL

Consequently	NULL
,	NULL
the	NULL
defect	NULL
in	NULL
1.3E2	NULL
would	NULL
be	NULL
located	NULL
before	NULL
the	NULL
Ser	NULL
32/36	NULL
phosphorylation	NULL
step	NULL
.	NULL

Alternatively	NULL
,	NULL
and	NULL
this	NULL
is	NULL
the	NULL
hypothesis	NULL
we	NULL
favor	NULL
,	NULL
the	NULL
action	NULL
of	NULL
the	NULL
phosphatase	NULL
inhibitors	NULL
does	NULL
not	NULL
reflect	NULL
the	NULL
physiological	NULL
mode	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Indeed	NULL
,	NULL
incubation	NULL
of	NULL
70Z/3	NULL
with	NULL
calyculin	NULL
A	NULL
or	NULL
okadaic	NULL
acid	NULL
results	NULL
in	NULL
a	NULL
broad	NULL
hyperphosphorylation	NULL
of	NULL
numerous	NULL
cellular	NULL
proteins	NULL
(	NULL
see	NULL
the	NULL
aberrant	NULL
migration	NULL
of	NULL
p50/relA	NULL
and	NULL
p50/pS50	NULL
dimers	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
among	NULL
them	NULL
IxBa	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
such	NULL
a	NULL
hyperphosphorylation	NULL
could	NULL
inadvertently	NULL
occur	NULL
on	NULL
Ser	NULL
32	NULL
and	NULL
36	NULL
,	NULL
triggering	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
the	NULL
translocation	NULL
of	NULL
p50/relA	NULL
in	NULL
1.3E2	NULL
would	NULL
only	NULL
confirm	NULL
the	NULL
existence	NULL
of	NULL
potentially	NULL
functional	NULL
IxB/	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
the	NULL
mutant	NULL
cell	NULL
line	NULL
but	NULL
would	NULL
not	NULL
bring	NULL
any	NULL
valuable	NULL
information	NULL
regarding	NULL
the	NULL
normal	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
process	NULL
.	NULL

Interestingly	NULL
,	NULL
however	NULL
,	NULL
calyculin	NULL
A	NULL
induces	NULL
IxBB	NULL
degradation	NULL
in	NULL
wt	NULL
70Z	NULL
,	NULL
/3	NULL
but	NULL
not	NULL
in	NULL
1.3E2	NULL
,	NULL
and	NULL
PDTC	NULL
blocks	NULL
this	NULL
degradation	NULL
.	NULL

This	NULL
demonstrates	NULL
that	NULL
the	NULL
PDTC-insensitive	NULL
pathway	NULL
that	NULL
is	NULL
observed	NULL
with	NULL
IxBa	NULL
is	NULL
not	NULL
active	NULL
on	NULL
IxBB	NULL
and	NULL
suggests	NULL
that	NULL
calyculin	NULL
A	NULL
can	NULL
act	NULL
at	NULL
several	NULL
levels	NULL
in	NULL
70Z/3	NULL
.	NULL

We	NULL
have	NULL
no	NULL
obvious	NULL
explanation	NULL
for	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
viral	NULL
transactivator	NULL
Tax	NULL
is	NULL
fully	NULL
active	NULL
in	NULL
1.3E2	NULL
.	NULL

If	NULL
,	NULL
like	NULL
LPS	NULL
or	NULL
PMA	NULL
,	NULL
it	NULL
acts	NULL
via	NULL
IxBa	NULL
phosphorylation	NULL
,	NULL
this	NULL
would	NULL
mean	NULL
that	NULL
the	NULL
phosphorylation	NULL
step	NULL
is	NULL
still	NULL
functional	NULL
in	NULL
1.3E2	NULL
and	NULL
,	NULL
consequently	NULL
,	NULL
would	NULL
locate	NULL
the	NULL
defect	NULL
at	NULL
a	NULL
step	NULL
upstream	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
that	NULL
we	NULL
observed	NULL
with	NULL
Tax	NULL
could	NULL
result	NULL
from	NULL
an	NULL
alternative	NULL
pathway	NULL
,	NULL
such	NULL
as	NULL
a	NULL
change	NULL
in	NULL
p105	NULL
processing	NULL
(	NULL
36	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Unfortunately	NULL
,	NULL
70Z/3	NULL
cells	NULL
are	NULL
difficult	NULL
to	NULL
transfect	NULL
and	NULL
the	NULL
transdominant	NULL
effect	NULL
of	NULL
an	NULL
IxBa	NULL
doubly	NULL
mutated	NULL
on	NULL
Ser	NULL
32/36	NULL
on	NULL
NF-xB	NULL
activation	NULL
by	NULL
Tax	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
possible	NULL
to	NULL
evaluate	NULL
.	NULL

A	NULL
summary	NULL
of	NULL
our	NULL
observations	NULL
is	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

11	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
in	NULL
the	NULL
1.3E2	NULL
cell	NULL
line	NULL
,	NULL
a	NULL
component	NULL
shared	NULL
by	NULL
several	NULL
distinct	NULL
stimuli	NULL
to	NULL
induce	NULL
the	NULL
degradation	NULL
of	NULL
IxBa	NULL
,	NULL
IxBB	NULL
,	NULL
and	NULL
IxBg	NULL
is	NULL
mutated	NULL
.	NULL

This	NULL
component	NULL
itself	NULL
or	NULL
the	NULL
pathway	NULL
in	NULL
which	NULL
it	NULL
participates	NULL
is	NULL
sensitive	NULL
to	NULL
antioxidants	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
other	NULL
pathways	NULL
that	NULL
do	NULL
not	NULL
use	NULL
this	NULL
step	NULL
are	NULL
fully	NULL
functional	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
believe	NULL
that	NULL
complementation	NULL
of	NULL
the	NULL
1.3E2	NULL
cell	NULL
line	NULL
will	NULL
allow	NULL
the	NULL
characterization	NULL
of	NULL
an	NULL
intermediate	NULL
that	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
NF-kB	NULL
activation	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
since	NULL
1.3E2	NULL
is	NULL
fully	NULL
viable	NULL
,	NULL
despite	NULL
a	NULL
perturbed	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
process	NULL
,	NULL
such	NULL
an	NULL
intermediate	NULL
may	NULL
represent	NULL
a	NULL
putative	NULL
target	NULL
for	NULL
immunosuppressive	NULL
or	NULL
anti-inflammatory	NULL
drugs	NULL
.	NULL

Finally	NULL
,	NULL
1.3E2	NULL
should	NULL
help	NULL
to	NULL
identify	NULL
new	NULL
targets	NULL
of	NULL
NF-kB	NULL
by	NULL
1448	NULL
COURTOIS	NULL
ET	NULL
AL	NULL
.	NULL

LPS	NULL
Taxol	NULL
PMA	NULL
IL-1	NULL
d.s	NULL
.	NULL

RNA	NULL
Calyculin	NULL
A	NULL
~All	NULL
**	NULL
``	NULL
_	NULL
}	NULL
E	NULL
}	NULL
=	NULL
|	NULL
--	NULL
--	NULL
PDTC	NULL
Calyculin	NULL
A	NULL
E	NULL
Okadaic	NULL
Acid	NULL
in	NULL
le	NULL
%	NULL
.	NULL

,	NULL
¢	NULL
E	NULL
&	NULL
#	NULL
+	NULL
Sorbitol	NULL
€	NULL
)	NULL
Ind	NULL
K	NULL
32	NULL
36	NULL
v	NULL
157	NULL
161	NULL
\	NULL
Sef	NULL
Ser	NULL
Ser	NULL
Ser	NULL
19	NULL
23	NULL
Ser	NULL
Ser	NULL
&	NULL
FIG	NULL
.	NULL

11	NULL
.	NULL

Proposed	NULL
location	NULL
of	NULL
the	NULL
defect	NULL
in	NULL
1.3E2	NULL
.	NULL

The	NULL
various	NULL
data	NULL
reported	NULL
in	NULL
this	NULL
study	NULL
,	NULL
together	NULL
with	NULL
some	NULL
not	NULL
shown	NULL
,	NULL
have	NULL
been	NULL
assembled	NULL
to	NULL
give	NULL
a	NULL
simplified	NULL
overview	NULL
.	NULL

The	NULL
dotted	NULL
arrow	NULL
indicates	NULL
the	NULL
pathway	NULL
that	NULL
is	NULL
defective	NULL
in	NULL
1.3E2	NULL
.	NULL

The	NULL
dual	NULL
effect	NULL
of	NULL
calyculin	NULL
A	NULL
is	NULL
explained	NULL
in	NULL
the	NULL
text	NULL
.	NULL

Moreover	NULL
,	NULL
to	NULL
simplify	NULL
the	NULL
figure	NULL
,	NULL
dsRNA	NULL
is	NULL
shown	NULL
to	NULL
act	NULL
on	NULL
IxBB	NULL
and	NULL
IxBg	NULL
,	NULL
but	NULL
this	NULL
point	NULL
remains	NULL
obscure	NULL
,	NULL
since	NULL
this	NULL
stimulus	NULL
is	NULL
a	NULL
weak	NULL
activator	NULL
of	NULL
NF-kB	NULL
.	NULL

Finally	NULL
,	NULL
since	NULL
IxBe	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
interact	NULL
with	NULL
p50-containing	NULL
NF-	NULL
«	NULL
B	NULL
molecules	NULL
(	NULL
61	NULL
)	NULL
,	NULL
a	NULL
tentative	NULL
association	NULL
with	NULL
molecules	NULL
like	NULL
c-rel/reIA	NULL
has	NULL
been	NULL
represented	NULL
.	NULL

comparing	NULL
gene	NULL
induction	NULL
between	NULL
this	NULL
mutant	NULL
and	NULL
wt	NULL
707	NULL
%	NULL
/3	NULL
.	NULL

Experiments	NULL
are	NULL
in	NULL
progress	NULL
to	NULL
address	NULL
these	NULL
issues	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
R.	NULL
Hay	NULL
(	NULL
St.	NULL
Andrews	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
,	NULL
for	NULL
the	NULL
kind	NULL
gift	NULL
of	NULL
anti-IxBa	NULL
antibody	NULL
,	NULL
J.	NULL
DiDonato	NULL
and	NULL
M.	NULL
Karin	NULL
(	NULL
UCSD	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
for	NULL
the	NULL
Flag-p65	NULL
expression	NULL
vector	NULL
and	NULL
anti-IxBa	NULL
antibody	NULL
,	NULL
R.	NULL
Weil	NULL
(	NULL
BMEG	NULL
,	NULL
Institut	NULL
Pasteur	NULL
)	NULL
and	NULL
S.	NULL
Ghosh	NULL
(	NULL
Yale	NULL
Uni-versity	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
Conn.	NULL
)	NULL
for	NULL
anti-I	NULL
«	NULL
BB	NULL
antibodies	NULL
,	NULL
and	NULL
N.	NULL
Rice	NULL
(	NULL
NCI	NULL
Frederick	NULL
,	NULL
Frederick	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

for	NULL
anti-p50	NULL
and	NULL
anti-p65	NULL
antibodies	NULL
.	NULL

We	NULL
thank	NULL
R.	NULL
Weil	NULL
for	NULL
useful	NULL
discussions	NULL
and	NULL
help	NULL
with	NULL
immunoprecipitations	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
J.	NULL
C.	NULL
Epinat	NULL
and	NULL
F.	NULL
Logeat	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

G.C	NULL
.	NULL

thanks	NULL
E.	NULL
Mufioz	NULL
(	NULL
University	NULL
of	NULL
Cordoba	NULL
,	NULL
Cordoba	NULL
,	NULL
Spain	NULL
)	NULL
for	NULL
encouragements	NULL
and	NULL
valuable	NULL
comments	NULL
during	NULL
the	NULL
initial	NULL
part	NULL
of	NULL
this	NULL
work	NULL
.	NULL

S.T.W	NULL
.	NULL

is	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
Wellcome	NULL
Travelling	NULL
Fellowship	NULL
.	NULL

This	NULL
research	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
ANRS	NULL
,	NULL
ARC	NULL
,	NULL
and	NULL
Ligue	NULL
Nationale	NULL
contre	NULL
le	NULL
Cancer	NULL
to	NULL
AL	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Alkalay	NULL
,	NULL
L	NULL
,	NULL
A.	NULL
Yaron	NULL
,	NULL
A.	NULL
Hatzubai	NULL
,	NULL
S.	NULL
Jung	NULL
,	NULL
A.	NULL
Avraham	NULL
,	NULL
O.	NULL
Gerlitz	NULL
,	NULL
I	NULL
Pashut-Lavon	NULL
,	NULL
and	NULL
Y.	NULL
Ben-Neriah	NULL
.	NULL

1995	NULL
.	NULL

In	NULL
vivo	NULL
stimulation	NULL
of	NULL
IxB	NULL
phosphorylation	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
activate	NULL
NF-xB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:1294-1301	NULL
.	NULL

2	NULL
.	NULL

Anderson	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
F.	NULL
J.	NULL
T.	NULL
Staal	NULL
,	NULL
C.	NULL
Gitler	NULL
,	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
.	NULL

1994	NULL
.	NULL

Separation	NULL
of	NULL
oxidant-initiated	NULL
and	NULL
redox-regulated	NULL
steps	NULL
in	NULL
the	NULL
NF-B	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
:	NULL
11527-11531	NULL
.	NULL

3	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141-179	NULL
.	NULL

4	NULL
.	NULL

Baldi	NULL
,	NULL
L.	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1996	NULL
.	NULL

Critical	NULL
role	NULL
for	NULL
lysines	NULL
21	NULL
and	NULL
22	NULL
in	NULL
signal-induced	NULL
,	NULL
ubiquitin-mediated	NULL
proteolysis	NULL
of	NULL
IxBae	NULL
:	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:376-379	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
Y.	NULL
Wano	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
induces	NULL
cellular	NULL
proteins	NULL
to	NULL
activate	NULL
the	NULL
xB	NULL
clement	NULL
in	NULL
the	NULL
IL-2	NULL
receptor	NULL
a	NULL
gene	NULL
.	NULL

Science	NULL
241:1652-1655.	NULL
.	NULL

Bass	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
J.	NULL
W.	NULL
Parce	NULL
,	NULL
L.	NULL
R.	NULL
Dechatelet	NULL
,	NULL
P.	NULL
Szejda	NULL
,	NULL
M.	NULL
C.	NULL
Seeds	NULL
,	NULL
and	NULL
M.	NULL
Thomas	NULL
.	NULL

1983	NULL
.	NULL

Flow	NULL
cytometric	NULL
studies	NULL
of	NULL
oxidative	NULL
product	NULL
formation	NULL
by	NULL
neutrophils	NULL
:	NULL
a	NULL
graded	NULL
response	NULL
to	NULL
membrane	NULL
stimulation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

130	NULL
;	NULL
1910-1917.	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
T.	NULL
S.	NULL
Finco	NULL
,	NULL
P.	NULL
V.	NULL
Nantermet	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
lead	NULL
to	NULL
phosphorylation	NULL
and	NULL
loss	NULL
of	NULL
IxBa	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3301-3310.	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
mitogen-inducible	NULL
gene	NULL
encoding	NULL
a	NULL
xB	NULL
DNA-binding	NULL
protein	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
and	NULL
to	NULL
cell-cycle	NULL
motifs	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
348:76-80.	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
P.	NULL
R.	NULL
Ryseck	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
mitogen-inducible	NULL
gene	NULL
product	NULL
related	NULL
to	NULL
p50-p105-NF-	NULL
«	NULL
B	NULL
participates	NULL
in	NULL
transactivation	NULL
through	NULL
a	NULL
xB	NULL
site	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:685-695	NULL
.	NULL

Brockman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
D.	NULL
C.	NULL
Scherer	NULL
,	NULL
T.	NULL
A.	NULL
McKinsey	NULL
,	NULL
S.	NULL
M.	NULL
Hall	NULL
,	NULL
X.	NULL
X.	NULL
Qi	NULL
,	NULL
W.	NULL
Y.	NULL
Lee	NULL
,	NULL
and	NULL
D.	NULL
Ballard	NULL
.	NULL

1995	NULL
.	NULL

Coupling	NULL
of	NULL
a	NULL
signal	NULL
response	NULL
domain	NULL
in	NULL
IxBa	NULL
to	NULL
multiple	NULL
pathways	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2809-2818	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Gerstberger	NULL
,	NULL
L.	NULL
Carlson	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1995	NULL
.	NULL

Control	NULL
of	NULL
IxBa	NULL
proteolysis	NULL
by	NULL
site-specific	NULL
,	NULL
signal-induced	NULL
phosphorylation	NULL
.	NULL

Science	NULL
267:1485-1488	NULL
.	NULL

Cahill	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
R.	NULL
Janknecht	NULL
,	NULL
and	NULL
A.	NULL
Nordheim	NULL
.	NULL

1996	NULL
.	NULL

Signalling	NULL
pathways	NULL
:	NULL
Jack	NULL
of	NULL
all	NULL
cascades	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

6:16-19	NULL
.	NULL

Chen	NULL
,	NULL
Z.	NULL
J.	NULL
,	NULL
J.	NULL
Hagler	NULL
,	NULL
V.	NULL
J.	NULL
Palombella	NULL
,	NULL
F.	NULL
Melandri	NULL
,	NULL
D.	NULL
Scherer	NULL
,	NULL
D.	NULL
Ballard	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1995	NULL
.	NULL

Signal-induced	NULL
site-specific	NULL
phosphorylation	NULL
targets	NULL
IxBa	NULL
to	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:1586-1597	NULL
.	NULL

Courtois	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

Activation	NULL
of	NULL
NF-kB	NULL
by	NULL
osmotic	NULL
shock	NULL
reveals	NULL
an	NULL
alternative	NULL
IxBa	NULL
degradation	NULL
pathway	NULL
.	NULL

Submitted	NULL
for	NULL
publication	NULL
.	NULL

DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
F.	NULL
Mercurio	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1995	NULL
.	NULL

Phosphorylation	NULL
of	NULL
I	NULL
«	NULL
xBa	NULL
precedes	NULL
but	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
its	NULL
dissociation	NULL
from	NULL
NF-kB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:1302-1311	NULL
.	NULL

DiDonato	NULL
,	NULL
J.	NULL
,	NULL
F.	NULL
Mercurio	NULL
,	NULL
C.	NULL
Rosette	NULL
,	NULL
J.	NULL
Wuli	NULL
,	NULL
H.	NULL
Suyang	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1996	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
inducible	NULL
IxB	NULL
phosphorylation	NULL
sites	NULL
that	NULL
signal	NULL
its	NULL
ubiquitination	NULL
and	NULL
degradation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1295-1304	NULL
.	NULL

Finco	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Beg	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1994	NULL
.	NULL

Inducible	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
:	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
its	NULL
dissociation	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
is	NULL
inhibited	NULL
by	NULL
protease	NULL
inhibitors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:11884-11888	NULL
.	NULL

Finco	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1995	NULL
.	NULL

Mechanistic	NULL
aspects	NULL
of	NULL
NF-kB	NULL
regulation	NULL
:	NULL
the	NULL
emerging	NULL
role	NULL
of	NULL
phosphorylation	NULL
and	NULL
proteolysis	NULL
.	NULL

Immunity	NULL
3:263-272	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
M.	NULL
Gifford	NULL
,	NULL
L.	NULL
R.	NULL
Rivicre	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
p50	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
homology	NULL
to	NULL
ref	NULL
and	NULL
dorsal	NULL
.	NULL

Cell	NULL
62:1019-1029	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
J.-D.	NULL
Lee	NULL
,	NULL
L.	NULL
Bibbs	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
MAP	NULL
kinase	NULL
targeted	NULL
by	NULL
endotoxin	NULL
and	NULL
hyperosmolarity	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Science	NULL
265:808-811	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
Beg	NULL
,	NULL
S.	NULL
M.	NULL
Tompkins	NULL
,	NULL
J.	NULL
S.	NULL
Morris	NULL
,	NULL
A.	NULL
D.	NULL
Yurochko	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Sampson-Johannes	NULL
,	NULL
K.	NULL
Mondal	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IxB-like	NULL
activity	NULL
.	NULL

Cell	NULL
65:1281-1289	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
I.	NULL
Alkalay	NULL
,	NULL
M.	NULL
Kronke	NULL
,	NULL
Y.	NULL
Ben	NULL
Neriah	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1993	NULL
.	NULL

Rapid	NULL
proteolysis	NULL
of	NULL
IxBa	NULL
«	NULL
is	NULL
necessary	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
365:182-185	NULL
.	NULL

Kanno	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1995	NULL
.	NULL

Evidence	NULL
in	NULL
support	NULL
of	NULL
a	NULL
role	NULL
for	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
in	NULL
activating	NULL
NF-	NULL
«	NULL
B	NULL
via	NULL
stimulation	NULL
of	NULL
signaling	NULL
pathways	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:11745-11748	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
J.	NULL
Vandekerckhove	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
O.	NULL
LeBail	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Urban	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
ref	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007-1018	NULL
.	NULL

Kyriakis	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
J.	NULL
Avruch	NULL
.	NULL

1996	NULL
.	NULL

Protein	NULL
kinase	NULL
cascades	NULL
activated	NULL
by	NULL
stress	NULL
and	NULL
inflammatory	NULL
cytokines	NULL
.	NULL

Bioessays	NULL
18:567-577	NULL
.	NULL

Lee	NULL
,	NULL
J.-D.	NULL
,	NULL
V.	NULL
Kravchenko	NULL
,	NULL
T.	NULL
N.	NULL
Kirkland	NULL
,	NULL
J.	NULL
Han	NULL
,	NULL
N.	NULL
Mackman	NULL
,	NULL
A.	NULL
Mori-arty	NULL
,	NULL
D.	NULL
Leturcq	NULL
,	NULL
P.	NULL
S.	NULL
Tobias	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
.	NULL

1993	NULL
.	NULL

Glycosyl-phospha-tidylinositol-anchored	NULL
or	NULL
integral	NULL
membrane	NULL
forms	NULL
of	NULL
CD14	NULL
mediate	NULL
identical	NULL
cellular	NULL
responses	NULL
to	NULL
endotoxin	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:9930-9934	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
G.	NULL
Nabel	NULL
.	NULL

1988	NULL
.	NULL

HTLV-1	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
333	NULL
:	NULL
776-778	NULL
.	NULL

Maggirwar	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
E.	NULL
Harhaj	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Sun	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
by	NULL
Tax	NULL
involves	NULL
degradation	NULL
of	NULL
IxBa	NULL
«	NULL
and	NULL
is	NULL
blocked	NULL
by	NULL
a	NULL
proteasome	NULL
inhib-itor	NULL
.	NULL

Oncogene	NULL
11:993-998	NULL
.	NULL

Mains	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
and	NULL
C.	NULL
H.	NULL
Sibley	NULL
.	NULL

1983	NULL
.	NULL

LPS-nonresponsive	NULL
variants	NULL
of	NULL
the	NULL
mouse	NULL
B	NULL
cell	NULL
lymphoma	NULL
70Z/3	NULL
:	NULL
isolation	NULL
and	NULL
characterization	NULL
.	NULL

Somatic	NULL
Cell	NULL
Genet	NULL
.	NULL

9:699-720	NULL
.	NULL

Matthews	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
E.	NULL
A.	NULL
Watson	NULL
,	NULL
S.	NULL
L.	NULL
Buckley	NULL
,	NULL
and	NULL
R.	NULL
T.	NULL
Hay	NULL
.	NULL

1993	NULL
.	NULL

Interaction	NULL
of	NULL
the	NULL
C-terminal	NULL
region	NULL
of	NULL
p105	NULL
with	NULL
the	NULL
nuclear	NULL
localisation	NULL
signal	NULL
of	NULL
p50	NULL
subunit	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:4516-4523	NULL
.	NULL

Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

McKinsey	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Brackman	NULL
,	NULL
D.	NULL
C.	NULL
Scherer	NULL
,	NULL
S.	NULL
W.	NULL
Al-Murrani	NULL
,	NULL
P.	NULL
L.	NULL
Green	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1996	NULL
.	NULL

Inactivation	NULL
of	NULL
IxBB	NULL
by	NULL
the	NULL
Tax	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
:	NULL
a	NULL
potential	NULL
mechanism	NULL
for	NULL
constitutive	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:2083-2090	NULL
.	NULL

Mellits	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
R.	NULL
T.	NULL
Hay	NULL
,	NULL
and	NULL
S.	NULL
Goodbourn	NULL
.	NULL

1993	NULL
.	NULL

Proteolytic	NULL
degradation	NULL
of	NULL
MAD3	NULL
(	NULL
IxBa	NULL
)	NULL
and	NULL
enhanced	NULL
processing	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
precursor	NULL
p105	NULL
are	NULL
obligatory	NULL
steps	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:5059-5066	NULL
.	NULL

Meyer	NULL
,	NULL
R.	NULL
,	NULL
E.	NULL
N.	NULL
Hatada	NULL
,	NULL
H.	NULL
P.	NULL
Hohman	NULL
,	NULL
M.	NULL
Haiker	NULL
,	NULL
C.	NULL
Bartsch	NULL
,	NULL
U.	NULL
Roth-lisberger	NULL
,	NULL
H.	NULL
W.	NULL
Labmi	NULL
,	NULL
E.	NULL
J.	NULL
Schlaeger	NULL
,	NULL
A.	NULL
P.	NULL
G.	NULL
M.	NULL
van	NULL
Loon	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
human	NULL
nuclear	NULL
factor	NULL
xB	NULL
:	NULL
the	NULL
level	NULL
of	NULL
its	NULL
mRNA	NULL
is	NULL
strongly	NULL
regulated	NULL
by	NULL
phorbol	NULL
ester	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:966-970	NULL
.	NULL

Mihm	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Ennen	NULL
,	NULL
U.	NULL
Pessara	NULL
,	NULL
R.	NULL
Kurth	NULL
,	NULL
and	NULL
W.	NULL
Droege	NULL
.	NULL

1991	NULL
.	NULL

Inhibition	NULL
of	NULL
HIV-1	NULL
replication	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
by	NULL
cysteine	NULL
and	NULL
cysteine	NULL
derivatives	NULL
.	NULL

AIDS	NULL
5:497-503	NULL
.	NULL

Miyamoto	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Maki	NULL
,	NULL
M.	NULL
J.	NULL
Schmitt	NULL
,	NULL
M.	NULL
Hatanaka	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1994	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
-induced	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
«	NULL
is	NULL
a	NULL
signal	NULL
for	NULL
its	NULL
degradation	NULL
but	NULL
not	NULL
for	NULL
dissociation	NULL
from	NULL
NF-xB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:12740-12744	NULL
.	NULL

Munoz	NULL
,	NULL
E.	NULL
,	NULL
G.	NULL
Courtois	NULL
,	NULL
P.	NULL
Veschambre	NULL
,	NULL
P.	NULL
Jalinot	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1994	NULL
.	NULL

Tax	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
through	NULL
dissociation	NULL
of	NULL
cytoplasmic	NULL
complexes	NULL
containing	NULL
p105	NULL
or	NULL
p100	NULL
but	NULL
does	NULL
not	NULL
induce	NULL
degradation	NULL
of	NULL
IxBo/MAD3	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:8035-8044	NULL
.	NULL

Neri	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
C.	NULL
Chang	NULL
,	NULL
L.	NULL
Lombardi	NULL
,	NULL
M.	NULL
Salina	NULL
,	NULL
P.	NULL
Corradini	NULL
,	NULL
A.	NULL
T.	NULL
Maiolo	NULL
,	NULL
R.	NULL
S.	NULL
K.	NULL
Chaganti	NULL
,	NULL
and	NULL
R.	NULL
Dalla-Favera	NULL
.	NULL

1991	NULL
.	NULL

B	NULL
cell	NULL
lymphoma-associated	NULL
chromosomal	NULL
associated	NULL
chromosomal	NULL
translocation	NULL
involves	NULL
candidate	NULL
oncogene	NULL
lyt-10	NULL
,	NULL
homologous	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
p30	NULL
.	NULL

Cell	NULL
67:1075-1087	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
M.	NULL
L.	NULL
MacKichan	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
precursor	NULL
of	NULL
NF-kB	NULL
p50	NULL
has	NULL
IxB-like	NULL
functions	NULL
.	NULL

Cell	NULL
71:243-253	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
D.	NULL
W.	NULL
Emery	NULL
,	NULL
and	NULL
C.	NULL
H.	NULL
Sibley	NULL
.	NULL

1990	NULL
.	NULL

1.3E2	NULL
,	NULL
a	NULL
variant	NULL
of	NULL
the	NULL
B	NULL
lymphoma	NULL
70Z	NULL
,	NULL
/3	NULL
,	NULL
defective	NULL
in	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
OTF-2	NULL
.	NULL

Immuno-genetics	NULL
31:73-78	NULL
.	NULL

Rousset	NULL
,	NULL
R.	NULL
,	NULL
C.	NULL
Desbois	NULL
,	NULL
F.	NULL
Bantignies	NULL
,	NULL
and	NULL
P.	NULL
Jalinot	NULL
.	NULL

1996	NULL
.	NULL

Effects	NULL
on	NULL
NF-	NULL
«	NULL
B1/p105	NULL
processing	NULL
of	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
HTLV-1	NULL
transactivator	NULL
Tax	NULL
and	NULL
the	NULL
proteasome	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
381:328-331	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
H.	NULL
Poteat	NULL
,	NULL
T.	NULL
H.	NULL
Tan	NULL
,	NULL
K.	NULL
Kawakami	NULL
,	NULL
R.	NULL
Roeder	NULL
,	NULL
W.	NULL
Haseltine	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1988	NULL
.	NULL

Cellular	NULL
transcription	NULL
factors	NULL
and	NULL
regulation	NULL
of	NULL
IL-2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
HTLV-1	NULL
tax	NULL
gene	NULL
product	NULL
.	NULL

Science	NULL
241:89-92	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Dillon	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
C.	NULL
H.	NULL
Chen	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
rel-related	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-xB	NULL
.	NULL

Science	NULL
251	NULL
:	NULL
1490-1493	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
J.	NULL
F.	NULL
Klement	NULL
,	NULL
T.	NULL
A.	NULL
Coleman	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1992	NULL
.	NULL

I-Rel	NULL
:	NULL
a	NULL
novel	NULL
rel-related	NULL
protein	NULL
that	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:745-760	NULL
.	NULL

Ryseck	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
P.	NULL
Bull	NULL
,	NULL
M.	NULL
Takamiya	NULL
,	NULL
V.	NULL
Bours	NULL
,	NULL
U.	NULL
Sicbenlist	NULL
,	NULL
P.	NULL
Dobrzanski	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1992	NULL
.	NULL

Rel-B	NULL
,	NULL
a	NULL
new	NULL
rel	NULL
family	NULL
transcription	NULL
activator	NULL
that	NULL
can	NULL
interact	NULL
with	NULL
p50-NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:674-684	NULL
.	NULL

Scherer	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Brockman	NULL
,	NULL
Z.	NULL
Chen	NULL
,	NULL
T.	NULL
Maniatis	NULL
,	NULL
and	NULL
D.	NULL
Ballard	NULL
.	NULL

1995	NULL
.	NULL

Signal-induced	NULL
degradation	NULL
of	NULL
IxB	NULL
«	NULL
requires	NULL
site-specific	NULL
ubiquitination	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:11259-11263	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

NF-kB	NULL
ACTIVATION-DEFICIENT	NULL
CELL	NULL
LINE	NULL
-	NULL
1449	NULL
Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
N.	NULL
D.	NULL
Perkins	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
P.	NULL
C.	NULL
Andrews	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
which	NULL
stimulates	NULL
HIV	NULL
transcription	NULL
in	NULL
synergy	NULL
with	NULL
p65	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
352:733-736	NULL
.	NULL

Schmidt	NULL
,	NULL
K.	NULL
N.	NULL
,	NULL
P.	NULL
Amstad	NULL
,	NULL
P.	NULL
Ceruti	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
roles	NULL
of	NULL
hydrogen	NULL
peroxide	NULL
and	NULL
superoxide	NULL
as	NULL
messengers	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-xB	NULL
.	NULL

Chem	NULL
.	NULL

Biol	NULL
.	NULL

2:13-22	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
role	NULL
of	NULL
oxygen	NULL
radicals	NULL
as	NULL
second	NULL
messengers	NULL
.	NULL

Trends	NULL
Cell	NULL
Biol	NULL
.	NULL

1:39-42	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Rieber	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1991	NULL
.	NULL

Reactive	NULL
oxygen	NULL
intermediates	NULL
as	NULL
apparently	NULL
widely	NULL
used	NULL
messengers	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
and	NULL
HIV-1	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:2247-2258	NULL
.	NULL

Shapiro	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Dinarello	NULL
.	NULL

1995	NULL
.	NULL

Osmotic	NULL
regulation	NULL
of	NULL
cytokine	NULL
synthesis	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:12230-12234	NULL
.	NULL

Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
K.	NULL
Brown	NULL
.	NULL

1994	NULL
.	NULL

Structure	NULL
,	NULL
regulation	NULL
,	NULL
and	NULL
function	NULL
of	NULL
NF-kB	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

10:405-455	NULL
.	NULL

Staal	NULL
,	NULL
F.	NULL
J.	NULL
T.	NULL
,	NULL
M.	NULL
Roederer	NULL
,	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
,	NULL
.	NULL

1991	NULL
.	NULL

Intracellular	NULL
thiols	NULL
regulate	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
xB	NULL
and	NULL
transcription	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:9943-9947	NULL
.	NULL

Sun	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
J.	NULL
Elwood	NULL
,	NULL
C.	NULL
Béraud	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
activation	NULL
of	NULL
NF-xB/Re	NULL
!	NULL

l	NULL
involves	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
-mediated	NULL
induction	NULL
of	NULL
the	NULL
c-re/	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7377-7384	NULL
.	NULL

Sun	NULL
,	NULL
S.	NULL
C	NULL
,	NULL
,	NULL
J.	NULL
Elwood	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1996	NULL
.	NULL

Both	NULL
amino-	NULL
and	NULL
carboxy-terminal	NULL
sequences	NULL
within	NULL
IxBa	NULL
regulate	NULL
its	NULL
inducible	NULL
degradation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1058-1065	NULL
.	NULL

Thompson	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
R.	NULL
J.	NULL
Phillips	NULL
,	NULL
H.	NULL
Erdjument-Bromage	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

1995	NULL
.	NULL

IxBB	NULL
regulates	NULL
the	NULL
persistent	NULL
response	NULL
in	NULL
a	NULL
biphasic	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Cell	NULL
80:573-582	NULL
.	NULL

Traenckner	NULL
,	NULL
E.	NULL
B.	NULL
M.	NULL
,	NULL
S.	NULL
Wilk	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
proteasome	NULL
inhibitor	NULL
prevents	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
stabilizes	NULL
a	NULL
newly	NULL
phosphorylated	NULL
form	NULL
of	NULL
IxBa	NULL
that	NULL
is	NULL
still	NULL
bound	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:5433-5441	NULL
.	NULL

Traenckner	NULL
,	NULL
E.	NULL
B.	NULL
M.	NULL
,	NULL
H.	NULL
L.	NULL
Pahl	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
K.	NULL
N.	NULL
Schmidt	NULL
,	NULL
S.	NULL
Wilk	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeverle	NULL
.	NULL

1995	NULL
.	NULL

Phosphorylation	NULL
of	NULL
human	NULL
IxBa	NULL
on	NULL
serines	NULL
32	NULL
and	NULL
36	NULL
controls	NULL
IxBa	NULL
proteolysis	NULL
and	NULL
NF-B	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
diverse	NULL
stimuli	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:2876-2883	NULL
.	NULL

Treisman	NULL
,	NULL
R.	NULL
1996	NULL
.	NULL

Regulation	NULL
of	NULL
transcription	NULL
by	NULL
MAP	NULL
kinase	NULL
cascades	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

8:205-215	NULL
.	NULL

Verma	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
J.	NULL
K.	NULL
Stevenson	NULL
,	NULL
E.	NULL
M.	NULL
Schwarz	NULL
,	NULL
D.	NULL
Van	NULL
Antwerp	NULL
,	NULL
S.	NULL
Miyamoto	NULL
.	NULL

1995	NULL
.	NULL

Rel/NF-	NULL
«	NULL
B/IxB	NULL
family	NULL
:	NULL
intimate	NULL
tales	NULL
of	NULL
association	NULL
and	NULL
dissociation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:2723-2735	NULL
.	NULL

59a.Weil	NULL
,	NULL
R.	NULL
,	NULL
M.	NULL
C.	NULL
Laurent-Winter	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

Regulation	NULL
of	NULL
IxBB	NULL
degra-	NULL
60	NULL
.	NULL

61	NULL
.	NULL

62.	NULL
dation	NULL
:	NULL
similarities	NULL
and	NULL
differences	NULL
with	NULL
IxBa	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
in	NULL
press	NULL
.	NULL

Whiteside	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
M.	NULL
K.	NULL
Ernst	NULL
,	NULL
O.	NULL
LeBail	NULL
,	NULL
C.	NULL
Laurent-Winter	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1995	NULL
.	NULL

N-	NULL
and	NULL
C-terminal	NULL
sequences	NULL
control	NULL
degradation	NULL
of	NULL
MAD3/	NULL
IxBa	NULL
in	NULL
response	NULL
to	NULL
inducers	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:5339-5345	NULL
.	NULL

Whiteside	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
J.-C.	NULL
Epinat	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

I	NULL
«	NULL
Be	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
IxB	NULL
family	NULL
,	NULL
controls	NULL
RelA	NULL
and	NULL
cRel	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
.	NULL

Embo	NULL
J.	NULL
,	NULL
in	NULL
press	NULL
.	NULL

Wilhemsen	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
K.	NULL
Eggleton	NULL
,	NULL
H.	NULL
M.	NULL
Temin	NULL
.	NULL

1984	NULL
.	NULL

Nucleic	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
oncogene	NULL
v-rel	NULL
in	NULL
reticuloendotheliosis	NULL
virus	NULL
strain	NULL
T	NULL
and	NULL
its	NULL
cellular	NULL
homolog	NULL
,	NULL
the	NULL
proto-oncogene	NULL
c-rel	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

52:172-182	NULL
.	NULL

